cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
ESCA	cis	1	rs1000113	chr5:150240076	LOC134466	chr5:150310000-150326146:-	0.47	4.44	1.66E-5	Crohn's disease	
ESCA	cis	1	rs10002332	chr4:129875301	C4orf33	chr4:130014829-130033842:+	0.47	6.72	3.13E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs10008757	chr4:76903036	NAAA	chr4:76831809-76862166:-	-0.33	-4.27	3.41E-5	Longevity	
ESCA	cis	1	rs10041072	chr5:150259642	LOC134466	chr5:150310000-150326146:-	0.55	5.54	1.22E-7	Crohn's disease	
ESCA	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.71	7.1	3.85E-11	Type 2 diabetes	
ESCA	cis	1	rs10051804	chr5:150226424	LOC134466	chr5:150310000-150326146:-	0.54	5.12	8.81E-7	Crohn's disease	
ESCA	cis	1	rs10051924	chr5:150226639	LOC134466	chr5:150310000-150326146:-	0.55	5.13	8.39E-7	Crohn's disease	
ESCA	cis	1	rs10052606	chr5:150272217	LOC134466	chr5:150310000-150326146:-	0.54	5.24	5.13E-7	Crohn's disease	
ESCA	cis	1	rs10053750	chr5:150270051	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs10057988	chr5:150272062	LOC134466	chr5:150310000-150326146:-	0.54	5.24	5.13E-7	Crohn's disease	
ESCA	cis	1	rs10058821	chr5:150226385	LOC134466	chr5:150310000-150326146:-	0.54	5.12	8.81E-7	Crohn's disease	
ESCA	cis	1	rs10058943	chr5:150226586	LOC134466	chr5:150310000-150326146:-	0.55	5.13	8.39E-7	Crohn's disease	
ESCA	cis	1	rs10061105	chr5:150255185	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs10065172	chr5:150227998	LOC134466	chr5:150310000-150326146:-	0.55	5.15	7.63E-7	Crohn's disease	
ESCA	cis	1	rs10078968	chr5:150244273	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs10128890	chr12:1903390	ADIPOR2	chr12:1800247-1897844:+	0.4	4.31	2.82E-5	Blood pressure (smoking interaction)	
ESCA	cis	1	rs10140433	chr14:74659989	LIN52	chr14:74551656-74667117:+	-0.3	-4.25	3.69E-5	Common traits (Other)	
ESCA	cis	1	rs10144220	chr14:74647904	LIN52	chr14:74551656-74667117:+	-0.32	-4.42	1.82E-5	Common traits (Other)	
ESCA	cis	1	rs10155981	chr7:22756463	RPS2P32	chr7:23530007-23531029:+	-0.55	-4.26	3.47E-5	Bilirubin levels	
ESCA	cis	1	rs10155987	chr7:22756536	RPS2P32	chr7:23530007-23531029:+	-0.55	-4.26	3.47E-5	Bilirubin levels	
ESCA	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.77	-9.98	1.67E-18	Homocysteine levels	
ESCA	cis	1	rs10175180	chr2:73673123	ALMS1P	chr2:73872046-73912692:+	0.42	4.3	2.98E-5	Metabolite levels	
ESCA	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.65	7.8	7.61E-13	Response to antipsychotic treatment	
ESCA	cis	1	rs10184268	chr2:73627044	ALMS1P	chr2:73872046-73912692:+	0.43	4.29	3.11E-5	Metabolite levels	
ESCA	cis	1	rs10186501	chr2:73697844	ALMS1P	chr2:73872046-73912692:+	0.42	4.34	2.55E-5	Metabolite levels	
ESCA	cis	1	rs10187416	chr2:73713741	ALMS1P	chr2:73872046-73912692:+	0.42	4.39	2.1E-5	Metabolite levels	
ESCA	cis	1	rs10189574	chr2:73698518	ALMS1P	chr2:73872046-73912692:+	0.43	4.41	1.88E-5	Metabolite levels	
ESCA	cis	1	rs10193373	chr2:281886	SH3YL1	chr2:218138-264810:-	-0.62	-8.4	2.38E-14	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs10193972	chr2:73717656	ALMS1P	chr2:73872046-73912692:+	0.43	4.4	2.0E-5	Metabolite levels	
ESCA	cis	1	rs10207220	chr2:73785046	ALMS1P	chr2:73872046-73912692:+	0.43	4.24	3.8E-5	Metabolite levels	
ESCA	cis	1	rs10215948	chr7:65747786	NCRNA00174	chr7:65841032-65865395:-	0.43	5.15	7.71E-7	Aortic root size	
ESCA	cis	1	rs10234018	chr7:66146284	NCRNA00174	chr7:65841032-65865395:-	0.4	5	1.5E-6	Aortic root size	
ESCA	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.52	6.66	4.31E-10	Paget's disease	
ESCA	cis	1	rs10244498	chr7:66116056	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.14	8.02E-7	Aortic root size	
ESCA	cis	1	rs10252765	chr7:66228732	NCRNA00174	chr7:65841032-65865395:-	-0.4	-4.84	3.06E-6	Aortic root size	
ESCA	cis	1	rs10256972	chr7:1039003	ZFAND2A	chr7:1192544-1199855:-	0.49	5.94	1.74E-8	Longevity;Endometriosis	
ESCA	cis	1	rs10257427	chr7:65743208	NCRNA00174	chr7:65841032-65865395:-	0.43	5.15	7.71E-7	Aortic root size	
ESCA	cis	1	rs10274773	chr7:66133578	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.15E-7	Aortic root size	
ESCA	cis	1	rs1030831	chr4:130025037	C4orf33	chr4:130014829-130033842:+	-0.51	-6.58	6.35E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1037147	chr4:130025873	C4orf33	chr4:130014829-130033842:+	-0.5	-6.86	1.48E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs10405348	chr19:12062853	ZNF763	chr19:12035900-12091196:+	-0.63	-4.78	3.88E-6	Multiple sclerosis	
ESCA	cis	1	rs10413462	chr19:12054636	ZNF763	chr19:12035900-12091196:+	-0.62	-4.56	1.03E-5	Multiple sclerosis	
ESCA	cis	1	rs1041748	chr22:24700854	POM121L9P	chr22:24647589-24661490:+	-0.44	-5.81	3.37E-8	Gut microbiome composition (summer)	
ESCA	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.75	-10	1.42E-18	Homocysteine levels	
ESCA	cis	1	rs1044825	chr12:1901485	ADIPOR2	chr12:1800247-1897844:+	-0.4	-4.46	1.56E-5	Blood pressure (smoking interaction)	
ESCA	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.63	-7.2	2.3E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.56	-6.23	3.98E-9	Response to antipsychotic treatment	
ESCA	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.6	-6.67	4.06E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.63	-7.18	2.55E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs10456622	chr6:49396453	MUT	chr6:49398994-49431031:-	0.54	6.01	1.2E-8	Folate pathway vitamin levels	
ESCA	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.75	7.67	1.61E-12	Type 2 diabetes	
ESCA	cis	1	rs10463240	chr5:150256853	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs10463307	chr5:150254620	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs10463310	chr5:150260905	LOC134466	chr5:150310000-150326146:-	0.57	5.67	6.45E-8	Crohn's disease	
ESCA	cis	1	rs10496191	chr2:73673798	ALMS1P	chr2:73872046-73912692:+	0.42	4.34	2.55E-5	Metabolite levels	
ESCA	cis	1	rs10496193	chr2:73773503	ALMS1P	chr2:73872046-73912692:+	0.43	4.26	3.42E-5	Metabolite levels	
ESCA	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.57	6.41	1.59E-9	Response to antipsychotic treatment	
ESCA	cis	1	rs10521115	chr16:20090645	C16orf62	chr16:19567040-19712444:+	-0.42	-4.26	3.48E-5	Attention deficit hyperactivity disorder (inattention symptoms)	
ESCA	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.65	8.84	1.76E-15	Homocysteine levels	
ESCA	cis	1	rs10739388	chr9:115977175	CDC26	chr9:116029290-116037869:-	-0.32	-4.88	2.57E-6	Hematology traits	
ESCA	cis	1	rs10744552	chr12:1900735	ADIPOR2	chr12:1800247-1897844:+	0.42	4.84	3.09E-6	Blood pressure (smoking interaction)	
ESCA	cis	1	rs10749860	chr1:46328210	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.67	6.45E-6	Body mass index	
ESCA	cis	1	rs10771431	chr12:9380859	LOC642846	chr12:9436253-9466684:+	0.31	4.78	3.98E-6	Breast size	
ESCA	cis	1	rs10789475	chr1:46304177	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.57	9.89E-6	Body mass index	
ESCA	cis	1	rs10789481	chr1:46383583	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.46	1.52E-5	Body mass index	
ESCA	cis	1	rs10789487	chr1:46420221	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.56	1.03E-5	Body mass index	
ESCA	cis	1	rs10804632	chr3:134294501	ANAPC13	chr3:134196547-134204865:-	0.44	5.35	3.0E-7	Height	
ESCA	cis	1	rs10838738	chr11:47663049	C1QTNF4	chr11:47611216-47615961:-	-0.65	-11.09	1.53E-21	Subjective well-being	
ESCA	cis	1	rs10838747	chr11:47716324	C1QTNF4	chr11:47611216-47615961:-	-0.64	-10.65	2.51E-20	Subjective well-being	
ESCA	cis	1	rs10838748	chr11:47716381	C1QTNF4	chr11:47611216-47615961:-	-0.64	-10.65	2.51E-20	Subjective well-being	
ESCA	cis	1	rs10838757	chr11:47763016	C1QTNF4	chr11:47611216-47615961:-	-0.66	-11.09	1.58E-21	Subjective well-being	
ESCA	cis	1	rs1085243	chr1:46544768	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs1085244	chr1:46563680	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs10874122	chr1:75235866	CRYZ	chr1:75171175-75199092:-	-0.45	-4.92	2.17E-6	Resistin levels	
ESCA	cis	1	rs10890352	chr1:46283628	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.34	2.55E-5	Body mass index	
ESCA	cis	1	rs10890354	chr1:46305347	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.53	1.13E-5	Body mass index	
ESCA	cis	1	rs10890361	chr1:46346234	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.58	9.36E-6	Body mass index	
ESCA	cis	1	rs10890363	chr1:46356148	CCDC163P	chr1:45960581-45965646:-	0.36	4.47	1.47E-5	Body mass index	
ESCA	cis	1	rs10935120	chr3:134233092	ANAPC13	chr3:134196547-134204865:-	-0.46	-5.73	4.86E-8	Height	
ESCA	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.61	-6.99	7.02E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.59	-6.59	6.22E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.61	-6.92	1.07E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.63	-7.2	2.3E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs11039255	chr11:47495746	C1QTNF4	chr11:47611216-47615961:-	-0.62	-10.18	4.75E-19	Subjective well-being	
ESCA	cis	1	rs11039390	chr11:47796295	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.18	8.91E-22	Subjective well-being	
ESCA	cis	1	rs11039412	chr11:47841581	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.22	6.77E-22	Subjective well-being	
ESCA	cis	1	rs11039426	chr11:47863119	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.22	6.77E-22	Subjective well-being	
ESCA	cis	1	rs11065750	chr12:111331016	TCHP	chr12:110338079-110391074:+	-0.58	-4.33	2.6E-5	Coronary heart disease	
ESCA	cis	1	rs11065751	chr12:111331156	TCHP	chr12:110338079-110391074:+	-0.64	-4.54	1.11E-5	Coronary heart disease	
ESCA	cis	1	rs11067231	chr12:109993603	MMAB	chr12:109991523-110011358:-	-0.32	-4.36	2.37E-5	HDL cholesterol	
ESCA	cis	1	rs1112137	chr1:247215375	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.1E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.52	-5.76	4.22E-8	Renal function-related traits (BUN)	
ESCA	cis	1	rs11123170	chr2:113978940	PAX8	chr2:113973575-114036498:-	-0.46	-5.62	8.46E-8	Renal function-related traits (BUN)	
ESCA	cis	1	rs11127188	chr2:28972852	TRMT61B	chr2:29072690-29093175:-	-0.36	-4.64	7.25E-6	Body mass index	
ESCA	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-0.97	-7.16	2.83E-11	Triptolide cytotoxicity	
ESCA	cis	1	rs11132254	chr4:185611592	MLF1IP	chr4:185615220-185655286:-	-0.5	-5.81	3.32E-8	Kawasaki disease	
ESCA	cis	1	rs11159067	chr14:74637444	LIN52	chr14:74551656-74667117:+	0.32	4.44	1.67E-5	Common traits (Other)	
ESCA	cis	1	rs11167515	chr5:150239471	LOC134466	chr5:150310000-150326146:-	0.54	4.98	1.61E-6	Crohn's disease	
ESCA	cis	1	rs11167518	chr5:150258920	LOC134466	chr5:150310000-150326146:-	0.55	5.46	1.81E-7	Crohn's disease	
ESCA	cis	1	rs11167519	chr5:150265407	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs11167520	chr5:150265639	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs11167521	chr5:150271785	LOC134466	chr5:150310000-150326146:-	0.54	5.24	5.13E-7	Crohn's disease	
ESCA	cis	1	rs11167526	chr5:150332481	LOC134466	chr5:150310000-150326146:-	0.63	5.1	9.7E-7	Crohn's disease	
ESCA	cis	1	rs11201312	chr10:81795778	LOC219347	chr10:81805991-81838949:-	0.53	5.07	1.07E-6	Chronic obstructive pulmonary disease-related biomarkers	
ESCA	cis	1	rs11201660	chr10:81854531	LOC219347	chr10:81805991-81838949:-	-0.51	-5.5	1.5E-7	Chronic obstructive pulmonary disease-related biomarkers	
ESCA	cis	1	rs112017572	chr19:12089903	ZNF763	chr19:12035900-12091196:+	-0.59	-4.56	1.01E-5	Multiple sclerosis	
ESCA	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.77	-9.98	1.67E-18	Homocysteine levels	
ESCA	cis	1	rs11211199	chr1:46287869	CCDC163P	chr1:45960581-45965646:-	-0.39	-4.75	4.48E-6	Body mass index	
ESCA	cis	1	rs11211208	chr1:46334256	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.57	9.77E-6	Body mass index	
ESCA	cis	1	rs11211230	chr1:46406767	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.4	1.98E-5	Body mass index	
ESCA	cis	1	rs11211234	chr1:46438787	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.62	7.84E-6	Body mass index	
ESCA	cis	1	rs11211241	chr1:46452683	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.61	8.11E-6	Body mass index	
ESCA	cis	1	rs113790048	chr19:12123995	ZNF763	chr19:12035900-12091196:+	-0.7	-4.94	1.97E-6	Multiple sclerosis	
ESCA	cis	1	rs1138273	chr3:134261437	ANAPC13	chr3:134196547-134204865:-	0.44	5.22	5.42E-7	Height	
ESCA	cis	1	rs1141321	chr6:49412433	MUT	chr6:49398994-49431031:-	0.44	4.81	3.55E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs114200987	chr14:35586916	PPP2R3C	chr14:35554679-35591679:-	0.51	4.35	2.47E-5	Atopic dermatitis	
ESCA	cis	1	rs114244137	chr5:150264753	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs114976176	chr2:264621	SH3YL1	chr2:218138-264810:-	-0.61	-8.07	1.67E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs11553746	chr2:272203	SH3YL1	chr2:218138-264810:-	-0.6	-8.05	1.78E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs11579634	chr1:46466391	CCDC163P	chr1:45960581-45965646:-	0.35	4.29	3.06E-5	Body mass index	
ESCA	cis	1	rs115965884	chr22:24594662	SUSD2	chr22:24577444-24585074:+	0.86	4.96	1.79E-6	Amyotrophic lateral sclerosis	
ESCA	cis	1	rs11605774	chr11:47832793	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.26	5.27E-22	Subjective well-being	
ESCA	cis	1	rs11611670	chr12:9385535	LOC642846	chr12:9436253-9466684:+	0.34	5.29	4.03E-7	Breast size	
ESCA	cis	1	rs11628710	chr14:74649280	LIN52	chr14:74551656-74667117:+	0.32	4.41	1.91E-5	Common traits (Other)	
ESCA	cis	1	rs11633958	chr15:78862064	CHRNA3	chr15:78885397-78913322:-	-0.49	-4.67	6.49E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs11633958	chr15:78862064	CHRNA5	chr15:78857906-78886458:+	-0.43	-4.35	2.47E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.27	-4.48	1.43E-5	Eye color traits	
ESCA	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.27	4.57	9.79E-6	Eye color traits	
ESCA	cis	1	rs11673344	chr19:37684966	ZNF781	chr19:38158650-38183216:-	-0.32	-5.07	1.11E-6	Obesity-related traits	
ESCA	cis	1	rs11689392	chr2:73622026	ALMS1P	chr2:73872046-73912692:+	0.43	4.3	3.01E-5	Metabolite levels	
ESCA	cis	1	rs11703914	chr22:24767602	POM121L9P	chr22:24647589-24661490:+	-0.45	-5.91	2.03E-8	Gut microbiome composition (summer)	
ESCA	cis	1	rs11706117	chr3:134212526	ANAPC13	chr3:134196547-134204865:-	0.47	5.72	5.24E-8	Height	
ESCA	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.46	5.6	9.31E-8	Height	
ESCA	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.72	7	6.81E-11	Type 2 diabetes	
ESCA	cis	1	rs11739619	chr5:150264662	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs11739677	chr5:150294883	LOC134466	chr5:150310000-150326146:-	0.52	4.74	4.71E-6	Crohn's disease	
ESCA	cis	1	rs11740172	chr5:150300278	LOC134466	chr5:150310000-150326146:-	0.47	4.31	2.85E-5	Crohn's disease	
ESCA	cis	1	rs11741861	chr5:150277909	LOC134466	chr5:150310000-150326146:-	-0.55	-5.04	1.28E-6	Crohn's disease	
ESCA	cis	1	rs11743488	chr5:150279218	LOC134466	chr5:150310000-150326146:-	0.51	4.52	1.19E-5	Crohn's disease	
ESCA	cis	1	rs11746108	chr5:150264622	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs11746807	chr5:150300419	LOC134466	chr5:150310000-150326146:-	0.47	4.25	3.58E-5	Crohn's disease	
ESCA	cis	1	rs11747065	chr5:150295486	LOC134466	chr5:150310000-150326146:-	0.52	4.74	4.71E-6	Crohn's disease	
ESCA	cis	1	rs11747270	chr5:150258867	LOC134466	chr5:150310000-150326146:-	-0.5	-5.01	1.42E-6	Crohn's disease	
ESCA	cis	1	rs11748151	chr5:150226292	LOC134466	chr5:150310000-150326146:-	0.54	5.12	8.81E-7	Crohn's disease	
ESCA	cis	1	rs11748158	chr5:150226345	LOC134466	chr5:150310000-150326146:-	0.54	5.12	8.81E-7	Crohn's disease	
ESCA	cis	1	rs11749391	chr5:150229066	LOC134466	chr5:150310000-150326146:-	0.54	5.08	1.05E-6	Crohn's disease	
ESCA	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.59	-6.34	2.29E-9	Response to antipsychotic treatment	
ESCA	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.58	-6.6	5.93E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs11763147	chr7:65326821	NCRNA00174	chr7:65841032-65865395:-	0.44	5.26	4.67E-7	Corneal structure	
ESCA	cis	1	rs11773829	chr7:66141074	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.04E-7	Aortic root size	
ESCA	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.76	-10.46	8.27E-20	Response to antipsychotic treatment	
ESCA	cis	1	rs11810993	chr1:46478793	CCDC163P	chr1:45960581-45965646:-	-0.4	-4.96	1.76E-6	Body mass index	
ESCA	cis	1	rs118110670	chr10:81792242	LOC219347	chr10:81805991-81838949:-	0.53	5.05	1.2E-6	Chronic obstructive pulmonary disease-related biomarkers	
ESCA	cis	1	rs11856184	chr15:43919162	ADAL	chr15:43622872-43646094:+	-0.57	-4.33	2.59E-5	Tumor biomarkers	
ESCA	cis	1	rs11856184	chr15:43919162	CATSPER2	chr15:43922774-43959900:-	-0.69	-7.12	3.44E-11	Tumor biomarkers	
ESCA	cis	1	rs11893832	chr2:88507537	THNSL2	chr2:88469835-88486145:+	-0.7	-4.92	2.15E-6	Plasma clusterin levels	
ESCA	cis	1	rs11901272	chr2:73720444	ALMS1P	chr2:73872046-73912692:+	0.41	4.32	2.79E-5	Metabolite levels	
ESCA	cis	1	rs11919350	chr3:134235970	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs11927068	chr3:134266321	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.45	-5.32	3.42E-7	Height	
ESCA	cis	1	rs11950957	chr5:150253914	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs11951694	chr5:150254338	LOC134466	chr5:150310000-150326146:-	0.53	5.25	4.8E-7	Crohn's disease	
ESCA	cis	1	rs11955172	chr5:150254378	LOC134466	chr5:150310000-150326146:-	0.53	5.25	4.8E-7	Crohn's disease	
ESCA	cis	1	rs11957134	chr5:150230950	LOC134466	chr5:150310000-150326146:-	-0.53	-4.92	2.13E-6	Crohn's disease	
ESCA	cis	1	rs11971949	chr7:65626014	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.04E-7	Aortic root size	
ESCA	cis	1	rs11974219	chr7:65647410	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.04E-7	Aortic root size	
ESCA	cis	1	rs11974264	chr7:65647582	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.04E-7	Aortic root size	
ESCA	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	0.78	7.85	5.93E-13	Educational attainment (years of education)	
ESCA	cis	1	rs12021587	chr1:46472759	CCDC163P	chr1:45960581-45965646:-	-0.39	-4.77	4.22E-6	Body mass index	
ESCA	cis	1	rs12025136	chr1:161980502	UHMK1	chr1:162466964-162493844:+	-0.25	-4.26	3.42E-5	QT interval	
ESCA	cis	1	rs12049588	chr1:46472422	CCDC163P	chr1:45960581-45965646:-	-0.39	-4.77	4.22E-6	Body mass index	
ESCA	cis	1	rs12054923	chr5:150249059	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs12122290	chr1:247215810	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.1E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs12130075	chr1:247218491	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.11E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs12139630	chr1:46350935	CCDC163P	chr1:45960581-45965646:-	-0.35	-4.35	2.44E-5	Body mass index	
ESCA	cis	1	rs12144263	chr1:46352446	CCDC163P	chr1:45960581-45965646:-	-0.35	-4.34	2.56E-5	Body mass index	
ESCA	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.61	-6.99	7.02E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs12171333	chr4:129879711	C4orf33	chr4:130014829-130033842:+	0.47	6.54	8.16E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.68	-7.77	9.07E-13	Response to antipsychotic treatment	
ESCA	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.58	-6.57	6.82E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs12192208	chr6:124693764	NKAIN2	chr6:124125069-125146784:+	0.38	4.5	1.33E-5	Neuroticism	
ESCA	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.58	-6.6	5.93E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.6	-6.69	3.56E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.63	-7.11	3.63E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs12196937	chr6:49382808	MUT	chr6:49398994-49431031:-	0.49	5.19	6.25E-7	Folate pathway vitamin levels	
ESCA	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.64	-7.43	6.33E-12	Response to antipsychotic treatment	
ESCA	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.66	-7.84	6.19E-13	Response to antipsychotic treatment	
ESCA	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.59	-6.76	2.45E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.58	-6.6	5.93E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.63	-7.17	2.69E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.63	-7.39	8.03E-12	Response to antipsychotic treatment	
ESCA	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.61	-6.99	7.02E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs12202075	chr6:49427655	MUT	chr6:49398994-49431031:-	0.46	4.93	2.1E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.63	-7.22	2.04E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.63	-7.22	2.04E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.71	-9.37	6.78E-17	Response to antipsychotic treatment	
ESCA	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.63	-7.2	2.24E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs12204812	chr6:124681503	NKAIN2	chr6:124125069-125146784:+	0.39	4.42	1.86E-5	Neuroticism	
ESCA	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.61	-7.02	6.16E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.63	-7.11	3.63E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.66	-7.84	6.19E-13	Response to antipsychotic treatment	
ESCA	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.65	-7.6	2.37E-12	Response to antipsychotic treatment	
ESCA	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.59	-6.76	2.45E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.61	-7.02	6.16E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.61	-7.02	6.16E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.59	-6.76	2.45E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.64	-7.57	2.85E-12	Response to antipsychotic treatment	
ESCA	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.61	-6.91	1.1E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.63	-7.2	2.3E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.6	-6.79	2.13E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.6	-6.8	2.04E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs12220777	chr10:81788104	LOC219347	chr10:81805991-81838949:-	-0.51	-4.52	1.21E-5	Chronic obstructive pulmonary disease-related biomarkers	
ESCA	cis	1	rs12251587	chr10:28475748	MKX	chr10:27961804-28034778:-	-0.36	-4.25	3.66E-5	Bone mineral density;Bone mineral density (paediatric, skull)	
ESCA	cis	1	rs12361031	chr11:47783076	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.18	8.91E-22	Subjective well-being	
ESCA	cis	1	rs12363232	chr11:47623890	C1QTNF4	chr11:47611216-47615961:-	-0.62	-10.66	2.34E-20	Subjective well-being	
ESCA	cis	1	rs12405451	chr1:46384326	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.47	1.5E-5	Body mass index	
ESCA	cis	1	rs12410060	chr1:75245848	CRYZ	chr1:75171175-75199092:-	-0.45	-4.91	2.2E-6	Resistin levels	
ESCA	cis	1	rs12411269	chr1:46271052	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.34	2.55E-5	Body mass index	
ESCA	cis	1	rs12416687	chr10:104629011	C10orf32	chr10:104613967-104624718:+	-0.6	-6.55	7.68E-10	Arsenic metabolism	
ESCA	cis	1	rs12418852	chr11:47868853	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.22	6.77E-22	Subjective well-being	
ESCA	cis	1	rs12419692	chr11:47624714	C1QTNF4	chr11:47611216-47615961:-	0.59	10.08	8.9E-19	Subjective well-being	
ESCA	cis	1	rs12421210	chr11:47779586	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.18	8.91E-22	Subjective well-being	
ESCA	cis	1	rs12443102	chr15:43932103	ADAL	chr15:43622872-43646094:+	-0.62	-4.88	2.51E-6	Tumor biomarkers	
ESCA	cis	1	rs12443102	chr15:43932103	CATSPER2	chr15:43922774-43959900:-	-0.64	-6.74	2.81E-10	Tumor biomarkers	
ESCA	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.64	-4.75	4.59E-6	Plasma clusterin levels	
ESCA	cis	1	rs12490835	chr3:134223730	ANAPC13	chr3:134196547-134204865:-	0.46	5.58	1.01E-7	Height	
ESCA	cis	1	rs12532998	chr7:65967459	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs12533997	chr7:65965377	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs12561806	chr1:46396776	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.4	1.98E-5	Body mass index	
ESCA	cis	1	rs12564541	chr1:46380237	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.47	1.5E-5	Body mass index	
ESCA	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.46	-5.04	1.27E-6	Forced vital capacity	
ESCA	cis	1	rs12637751	chr3:134266124	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs12652003	chr5:150231945	LOC134466	chr5:150310000-150326146:-	0.54	4.66	6.51E-6	Crohn's disease	
ESCA	cis	1	rs12656538	chr5:150251380	LOC134466	chr5:150310000-150326146:-	0.6	5.47	1.73E-7	Crohn's disease	
ESCA	cis	1	rs12659118	chr5:150324622	LOC134466	chr5:150310000-150326146:-	0.59	4.9	2.37E-6	Crohn's disease	
ESCA	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.6	-6.68	3.71E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.63	-7.2	2.24E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.67	7.88	4.9E-13	Response to antipsychotic treatment	
ESCA	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.54	6.43	1.4E-9	Response to antipsychotic treatment	
ESCA	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.63	-7.11	3.63E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs1267817	chr7:66110040	CRCP	chr7:65579805-65619551:+	-0.58	-4.38	2.18E-5	Gout	
ESCA	cis	1	rs1267818	chr7:66107024	CRCP	chr7:65579805-65619551:+	-0.58	-4.38	2.18E-5	Gout	
ESCA	cis	1	rs12698523	chr7:65968113	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs12787330	chr11:47812311	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.22	6.77E-22	Subjective well-being	
ESCA	cis	1	rs12921135	chr16:20087455	C16orf62	chr16:19567040-19712444:+	-0.44	-4.38	2.15E-5	Attention deficit hyperactivity disorder (inattention symptoms)	
ESCA	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.26	4.29	3.08E-5	Eye color traits	
ESCA	cis	1	rs13006376	chr2:38914251	GEMIN6	chr2:38978676-39009104:+	-0.42	-4.48	1.39E-5	5-HTT brain serotonin transporter levels	
ESCA	cis	1	rs13012704	chr2:38918793	GEMIN6	chr2:38978676-39009104:+	-0.41	-4.33	2.64E-5	5-HTT brain serotonin transporter levels	
ESCA	cis	1	rs13056719	chr22:24724099	POM121L9P	chr22:24647589-24661490:+	-0.44	-5.74	4.77E-8	Gut microbiome composition (summer)	
ESCA	cis	1	rs13059720	chr3:134242021	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs13071551	chr3:134310867	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.03	1.33E-6	Height	
ESCA	cis	1	rs13081177	chr3:134289860	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.03	1.33E-6	Height	
ESCA	cis	1	rs13081688	chr3:134259954	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs13087875	chr3:134261123	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs13089966	chr3:134279197	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs13090969	chr3:134307257	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.03	1.33E-6	Height	
ESCA	cis	1	rs13096604	chr3:134250099	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs13109003	chr4:129975969	C4orf33	chr4:130014829-130033842:+	-0.47	-6.14	6.5E-9	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs13130762	chr4:130022875	C4orf33	chr4:130014829-130033842:+	-0.51	-6.87	1.39E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1316952	chr12:124399550	DNAH10	chr12:124247042-124420265:+	0.75	4.3	2.95E-5	Visceral adipose tissue adjusted for BMI;Visceral adipose tissue/subcutaneous adipose tissue ratio	
ESCA	cis	1	rs1317149	chr11:47486885	C1QTNF4	chr11:47611216-47615961:-	-0.62	-10.39	1.23E-19	Subjective well-being	
ESCA	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.59	-6.76	2.45E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.59	-6.59	6.22E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.79	-10.76	1.22E-20	Response to antipsychotic treatment	
ESCA	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.68	-8.12	1.18E-13	Response to antipsychotic treatment	
ESCA	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	0.34	4.63	7.56E-6	Bone mineral density	
ESCA	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	0.35	4.86	2.84E-6	Bone mineral density	
ESCA	cis	1	rs1331215	chr20:3376565	ITPA	chr20:3190056-3204504:+	-0.4	-4.25	3.64E-5	IFN-related cytopenia	
ESCA	cis	1	rs13322305	chr3:134310791	ANAPC13	chr3:134196547-134204865:-	0.44	5.33	3.36E-7	Height	
ESCA	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.79	8.66	5.15E-15	Diastolic blood pressure	
ESCA	cis	1	rs13361189	chr5:150223387	LOC134466	chr5:150310000-150326146:-	0.49	4.69	5.91E-6	Crohn's disease	
ESCA	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.65	-7.6	2.37E-12	Response to antipsychotic treatment	
ESCA	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.62	-7.1	3.95E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs13387221	chr2:44135314	LRPPRC	chr2:44113363-44223144:-	-0.39	-4.88	2.6E-6	Intelligence (childhood)	
ESCA	cis	1	rs13398075	chr2:202376269	PPIL3	chr2:201735680-201753999:-	0.75	4.29	3.06E-5	Rheumatoid arthritis	
ESCA	cis	1	rs13431267	chr2:73782200	ALMS1P	chr2:73872046-73912692:+	0.43	4.24	3.8E-5	Metabolite levels	
ESCA	cis	1	rs1357762	chr3:134264859	ANAPC13	chr3:134196547-134204865:-	0.44	5.3	3.83E-7	Height	
ESCA	cis	1	rs1363055	chr7:65943275	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5	1.5E-6	Aortic root size	
ESCA	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.55	-6.29	2.9E-9	Type 2 diabetes	
ESCA	cis	1	rs138544659	chr15:78900701	CHRNA5	chr15:78857906-78886458:+	-0.45	-5.36	2.92E-7	Post bronchodilator FEV1;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs140330585	chr15:78866445	CHRNA3	chr15:78885397-78913322:-	-0.45	-4.39	2.06E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs141518190	chr15:78900647	CHRNA5	chr15:78857906-78886458:+	-0.45	-5.36	2.92E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.63	-7.22	2.04E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.71	7.57	2.89E-12	Type 2 diabetes	
ESCA	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.77	8.31	3.94E-14	Type 2 diabetes	
ESCA	cis	1	rs1428551	chr5:150259832	LOC134466	chr5:150310000-150326146:-	0.55	5.46	1.81E-7	Crohn's disease	
ESCA	cis	1	rs1428552	chr5:150259831	LOC134466	chr5:150310000-150326146:-	0.55	5.46	1.81E-7	Crohn's disease	
ESCA	cis	1	rs1428554	chr5:150257616	LOC134466	chr5:150310000-150326146:-	0.57	5.65	7.09E-8	Crohn's disease	
ESCA	cis	1	rs1428555	chr5:150257391	LOC134466	chr5:150310000-150326146:-	-0.55	-5.5	1.46E-7	Crohn's disease	
ESCA	cis	1	rs146009840	chr15:78906177	CHRNA3	chr15:78885397-78913322:-	-0.51	-4.93	2.08E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs146009840	chr15:78906177	CHRNA5	chr15:78857906-78886458:+	-0.45	-4.66	6.78E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs147144681	chr15:78900908	CHRNA3	chr15:78885397-78913322:-	-0.48	-4.64	7.18E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs147144681	chr15:78900908	CHRNA5	chr15:78857906-78886458:+	-0.43	-4.39	2.02E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs147499554	chr15:78900650	CHRNA5	chr15:78857906-78886458:+	-0.45	-5.36	2.92E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.46	5.57	1.05E-7	Height	
ESCA	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.49	-6.44	1.37E-9	Ankylosing spondylitis	
ESCA	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.57	6.63	4.89E-10	Ankylosing spondylitis	
ESCA	cis	1	rs1534025	chr3:134313304	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.03	1.33E-6	Height	
ESCA	cis	1	rs1534026	chr3:134284767	ANAPC13	chr3:134196547-134204865:-	0.44	5.3	3.88E-7	Height	
ESCA	cis	1	rs1540651	chr7:65650121	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.04E-7	Aortic root size	
ESCA	cis	1	rs1544549	chr7:66090663	NCRNA00174	chr7:65841032-65865395:-	0.4	4.61	8.36E-6	Aortic root size	
ESCA	cis	1	rs1553609	chr7:66197139	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.14	7.92E-7	Aortic root size	
ESCA	cis	1	rs1553610	chr7:66197233	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.24E-7	Aortic root size	
ESCA	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.74	7.75	1.04E-12	Type 2 diabetes	
ESCA	cis	1	rs1565531	chr7:65663113	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.04E-7	Aortic root size	
ESCA	cis	1	rs1573897	chr1:247215054	ZNF695	chr1:247108854-247242069:-	-0.39	-4.44	1.64E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.56	-6.41	1.6E-9	Response to antipsychotic treatment	
ESCA	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.63	-7.22	2.04E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs1618893	chr7:66096119	CRCP	chr7:65579805-65619551:+	-0.54	-4.36	2.31E-5	Diabetic kidney disease	
ESCA	cis	1	rs1638734	chr7:66097539	CRCP	chr7:65579805-65619551:+	-0.58	-4.37	2.24E-5	Diabetic kidney disease	
ESCA	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.69	4.29	3.08E-5	Rheumatoid arthritis	
ESCA	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.74	-10.01	1.39E-18	Response to antipsychotic treatment	
ESCA	cis	1	rs16891378	chr6:26188864	HIST1H4F	chr6:26240654-26241021:+	0.47	4.59	9.01E-6	Renal underexcretion gout;Gout	
ESCA	cis	1	rs1699379	chr4:129992337	C4orf33	chr4:130014829-130033842:+	-0.46	-5.99	1.36E-8	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1699389	chr4:130004079	C4orf33	chr4:130014829-130033842:+	-0.47	-6.23	4.06E-9	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1699391	chr4:130005096	C4orf33	chr4:130014829-130033842:+	-0.47	-6.23	4.06E-9	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1699392	chr4:130022347	C4orf33	chr4:130014829-130033842:+	-0.51	-6.87	1.39E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1699393	chr4:130019352	C4orf33	chr4:130014829-130033842:+	-0.5	-6.72	3.03E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1699394	chr4:130019312	C4orf33	chr4:130014829-130033842:+	-0.5	-6.74	2.78E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1707304	chr1:46598269	CCDC163P	chr1:45960581-45965646:-	-0.34	-4.24	3.71E-5	Body mass index	
ESCA	cis	1	rs1707321	chr1:46505309	CCDC163P	chr1:45960581-45965646:-	-0.41	-5.18	6.61E-7	Body mass index	
ESCA	cis	1	rs1707335	chr1:46571921	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs1707336	chr1:46493460	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.7	5.53E-6	Body mass index	
ESCA	cis	1	rs1707340	chr1:46514942	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.81	3.5E-6	Body mass index	
ESCA	cis	1	rs17096228	chr14:74558669	LIN52	chr14:74551656-74667117:+	0.33	4.59	8.95E-6	Common traits (Other)	
ESCA	cis	1	rs17111376	chr5:150226899	LOC134466	chr5:150310000-150326146:-	0.54	5.12	8.81E-7	Crohn's disease	
ESCA	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.79	14.32	2.13E-30	Carotid intima media thickness	
ESCA	cis	1	rs17496332	chr1:107546375	PRMT6	chr1:107599267-107601907:+	0.48	6.63	5.07E-10	Sex hormone-binding globulin levels	
ESCA	cis	1	rs17566701	chr7:66193183	NCRNA00174	chr7:65841032-65865395:-	-0.42	-4.92	2.13E-6	Aortic root size	
ESCA	cis	1	rs1757924	chr4:130019599	C4orf33	chr4:130014829-130033842:+	-0.51	-6.89	1.22E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1757925	chr4:130020791	C4orf33	chr4:130014829-130033842:+	0.51	6.87	1.39E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1757927	chr4:130022069	C4orf33	chr4:130014829-130033842:+	-0.51	-6.87	1.39E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1757928	chr4:130022161	C4orf33	chr4:130014829-130033842:+	-0.51	-6.87	1.39E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1757930	chr4:130022356	C4orf33	chr4:130014829-130033842:+	-0.5	-6.74	2.78E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1757935	chr4:130023759	C4orf33	chr4:130014829-130033842:+	-0.51	-6.87	1.39E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.4	-4.42	1.85E-5	Forced vital capacity	
ESCA	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.52	-6.4	1.7E-9	Temperament	
ESCA	cis	1	rs1768803	chr1:46546208	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs1768816	chr1:46528599	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.46	5.54	1.24E-7	Height	
ESCA	cis	1	rs17713396	chr2:227201	SH3YL1	chr2:218138-264810:-	-0.62	-7.95	3.32E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs17713729	chr2:249092	SH3YL1	chr2:218138-264810:-	-0.59	-7.66	1.76E-12	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs17714252	chr2:285471	SH3YL1	chr2:218138-264810:-	-0.61	-8.14	1.11E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs17727568	chr5:150244688	LOC134466	chr5:150310000-150326146:-	0.59	5.41	2.3E-7	Crohn's disease	
ESCA	cis	1	rs17800886	chr5:150309539	LOC134466	chr5:150310000-150326146:-	0.56	5.06	1.13E-6	Crohn's disease	
ESCA	cis	1	rs17800987	chr5:150323428	LOC134466	chr5:150310000-150326146:-	0.58	4.98	1.62E-6	Crohn's disease	
ESCA	cis	1	rs1796220	chr7:66062100	CRCP	chr7:65579805-65619551:+	-0.56	-4.26	3.51E-5	Diabetic kidney disease	
ESCA	cis	1	rs181394970	chr2:86776235	ST3GAL5	chr2:86066271-86116157:-	0.64	5.07	1.07E-6	Glomerular filtration rate in chronic kidney disease	
ESCA	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.46	5.5	1.46E-7	Height	
ESCA	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.47	5.85	2.66E-8	Height	
ESCA	cis	1	rs1816256	chr5:150272853	LOC134466	chr5:150310000-150326146:-	0.54	5.24	5.13E-7	Crohn's disease	
ESCA	cis	1	rs1820682	chr5:150262142	LOC134466	chr5:150310000-150326146:-	0.57	5.67	6.45E-8	Crohn's disease	
ESCA	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.72	7.61	2.3E-12	Type 2 diabetes	
ESCA	cis	1	rs1854774	chr4:129988405	C4orf33	chr4:130014829-130033842:+	-0.46	-5.99	1.36E-8	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.59	-6.71	3.19E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.61	-6.99	7.02E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.74	7.75	1.04E-12	Type 2 diabetes	
ESCA	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.47	5.85	2.66E-8	Height	
ESCA	cis	1	rs1863998	chr5:150271753	LOC134466	chr5:150310000-150326146:-	0.54	5.24	5.13E-7	Crohn's disease	
ESCA	cis	1	rs1874883	chr3:134205071	ANAPC13	chr3:134196547-134204865:-	0.44	5.29	3.93E-7	Height	
ESCA	cis	1	rs1880376	chr3:134270347	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs1880377	chr3:134270468	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs1896707	chr5:150245129	LOC134466	chr5:150310000-150326146:-	0.55	5.48	1.65E-7	Crohn's disease	
ESCA	cis	1	rs1896708	chr5:150245076	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs1896709	chr5:150245032	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.72	7.28	1.43E-11	Type 2 diabetes	
ESCA	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.8	-11.02	2.4E-21	Response to antipsychotic treatment	
ESCA	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.63	-7.39	8.0E-12	Response to antipsychotic treatment	
ESCA	cis	1	rs1917130	chr3:134313773	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.08	1.05E-6	Height	
ESCA	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.57	-6.55	7.44E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs1968225	chr7:65874773	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.94	-8.38	2.72E-14	Schizophrenia	
ESCA	cis	1	rs1981798	chr7:65954903	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5	1.5E-6	Aortic root size	
ESCA	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.71	7.64	1.95E-12	Diastolic blood pressure	
ESCA	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.63	-7.39	8.0E-12	Response to antipsychotic treatment	
ESCA	cis	1	rs199953	chr1:181593301	CACNA1E	chr1:181452716-181770713:+	-0.49	-4.64	7.35E-6	Body mass index (change over time)	
ESCA	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.63	-7.2	2.24E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs2003301	chr7:66147656	NCRNA00174	chr7:65841032-65865395:-	0.43	5.12	8.8E-7	Aortic root size	
ESCA	cis	1	rs2004711	chr5:150225068	LOC134466	chr5:150310000-150326146:-	0.54	5.12	8.81E-7	Crohn's disease	
ESCA	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.46	-5.09	9.98E-7	Forced vital capacity	
ESCA	cis	1	rs2028299	chr15:90374257	AP3S2	chr15:90373832-90456222:-	-0.52	-5.4	2.42E-7	Type 2 diabetes	
ESCA	cis	1	rs2036264	chr7:65799904	NCRNA00174	chr7:65841032-65865395:-	0.43	5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs2042133	chr7:65931922	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5	1.5E-6	Aortic root size	
ESCA	cis	1	rs2055682	chr7:66260289	NCRNA00174	chr7:65841032-65865395:-	-0.41	-4.77	4.14E-6	Aortic root size	
ESCA	cis	1	rs2056486	chr2:73717567	ALMS1P	chr2:73872046-73912692:+	0.43	4.4	2.0E-5	Metabolite levels	
ESCA	cis	1	rs2056603	chr3:134312749	ANAPC13	chr3:134196547-134204865:-	0.44	5.33	3.36E-7	Height	
ESCA	cis	1	rs2056604	chr3:134312648	ANAPC13	chr3:134196547-134204865:-	0.44	5.33	3.36E-7	Height	
ESCA	cis	1	rs2058805	chr12:109998591	MMAB	chr12:109991523-110011358:-	-0.33	-4.61	8.36E-6	HDL cholesterol	
ESCA	cis	1	rs2072293	chr14:74537885	LIN52	chr14:74551656-74667117:+	0.31	4.33	2.58E-5	Common traits (Other)	
ESCA	cis	1	rs2077593	chr7:65892530	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5	1.5E-6	Aortic root size	
ESCA	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.77	-9.98	1.67E-18	Homocysteine levels	
ESCA	cis	1	rs2083634	chr4:129976478	C4orf33	chr4:130014829-130033842:+	-0.47	-6.14	6.5E-9	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs2087647	chr7:65593188	NCRNA00174	chr7:65841032-65865395:-	0.43	5.27	4.41E-7	Aortic root size	
ESCA	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.78	7.77	9.26E-13	Type 2 diabetes	
ESCA	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	0.73	7.48	4.87E-12	Type 2 diabetes	
ESCA	cis	1	rs2115069	chr5:150252365	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs2126129	chr2:212548	SH3YL1	chr2:218138-264810:-	-0.6	-7.7	1.36E-12	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.54	-6.96	8.29E-11	Kawasaki disease	
ESCA	cis	1	rs2140195	chr2:73702344	ALMS1P	chr2:73872046-73912692:+	0.43	4.4	2.0E-5	Metabolite levels	
ESCA	cis	1	rs2143950	chr14:35572357	PPP2R3C	chr14:35554679-35591679:-	0.53	4.59	8.97E-6	Atopic dermatitis	
ESCA	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.76	-10.46	8.27E-20	Response to antipsychotic treatment	
ESCA	cis	1	rs2169751	chr2:28966758	TRMT61B	chr2:29072690-29093175:-	-0.35	-4.36	2.35E-5	Body mass index	
ESCA	cis	1	rs2173763	chr3:122329160	IQCB1	chr3:121488610-121553926:-	-0.49	-4.44	1.7E-5	Major depressive disorder	
ESCA	cis	1	rs2177601	chr3:134245434	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs2198042	chr4:129885499	C4orf33	chr4:130014829-130033842:+	0.47	6.59	6.24E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs2210913	chr1:157668993	FCRL3	chr1:157646278-157670775:-	0.29	4.97	1.69E-6	Type 1 diabetes autoantibodies	
ESCA	cis	1	rs2217266	chr5:150272621	LOC134466	chr5:150310000-150326146:-	0.54	5.24	5.13E-7	Crohn's disease	
ESCA	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.36	4.92	2.13E-6	Homocysteine levels	
ESCA	cis	1	rs2239557	chr14:74551970	LIN52	chr14:74551656-74667117:+	0.33	4.59	8.95E-6	Common traits (Other)	
ESCA	cis	1	rs2245715	chr15:43818052	ADAL	chr15:43622872-43646094:+	-0.56	-4.89	2.4E-6	Tumor biomarkers	
ESCA	cis	1	rs2245715	chr15:43818052	CATSPER2	chr15:43922774-43959900:-	-0.39	-4.24	3.74E-5	Tumor biomarkers	
ESCA	cis	1	rs2251844	chr15:43836478	ADAL	chr15:43622872-43646094:+	-0.57	-5.08	1.05E-6	Tumor biomarkers	
ESCA	cis	1	rs2251844	chr15:43836478	CATSPER2	chr15:43922774-43959900:-	-0.43	-4.77	4.2E-6	Tumor biomarkers	
ESCA	cis	1	rs2255042	chr15:43834318	ADAL	chr15:43622872-43646094:+	0.55	4.94	2.0E-6	Tumor biomarkers	
ESCA	cis	1	rs2255042	chr15:43834318	CATSPER2	chr15:43922774-43959900:-	0.42	4.67	6.42E-6	Tumor biomarkers	
ESCA	cis	1	rs2255051	chr15:43846161	ADAL	chr15:43622872-43646094:+	-0.56	-5.02	1.35E-6	Tumor biomarkers	
ESCA	cis	1	rs2255051	chr15:43846161	CATSPER2	chr15:43922774-43959900:-	-0.46	-5.22	5.45E-7	Tumor biomarkers	
ESCA	cis	1	rs2255440	chr15:43830467	ADAL	chr15:43622872-43646094:+	-0.56	-4.89	2.4E-6	Tumor biomarkers	
ESCA	cis	1	rs2255440	chr15:43830467	CATSPER2	chr15:43922774-43959900:-	-0.39	-4.24	3.74E-5	Tumor biomarkers	
ESCA	cis	1	rs2260160	chr15:43895643	ADAL	chr15:43622872-43646094:+	-0.55	-4.64	7.12E-6	Tumor biomarkers	
ESCA	cis	1	rs2260160	chr15:43895643	CATSPER2	chr15:43922774-43959900:-	-0.56	-6.32	2.51E-9	Tumor biomarkers	
ESCA	cis	1	rs2269558	chr16:682250	WFIKKN1	chr16:679239-684116:+	0.39	4.46	1.51E-5	Height	
ESCA	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-0.76	-9.02	5.65E-16	Diastolic blood pressure	
ESCA	cis	1	rs2275426	chr1:46487552	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.06	1.15E-6	Body mass index	
ESCA	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.9	-7.87	5.01E-13	Cholesterol, total	
ESCA	cis	1	rs2286379	chr12:1902164	ADIPOR2	chr12:1800247-1897844:+	-0.38	-4.51	1.27E-5	Blood pressure (smoking interaction)	
ESCA	cis	1	rs2286684	chr7:66129830	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.15E-7	Aortic root size	
ESCA	cis	1	rs2288073	chr2:24413298	C2orf84	chr2:24397531-24414566:+	-0.5	-4.99	1.56E-6	Venous thromboembolism (SNP x SNP interaction)	
ESCA	cis	1	rs2290850	chr11:47807774	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.21	7.31E-22	Subjective well-being	
ESCA	cis	1	rs2290911	chr2:224919	SH3YL1	chr2:218138-264810:-	-0.59	-7.64	1.93E-12	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.51	6.66	4.13E-10	Cognitive function	
ESCA	cis	1	rs2303759	chr19:49869051	DKKL1	chr19:49867042-49878371:+	-0.42	-5.59	9.64E-8	Multiple sclerosis	
ESCA	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.58	-6.54	7.94E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs2344180	chr5:150267357	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs2344181	chr5:150262574	LOC134466	chr5:150310000-150326146:-	0.57	5.67	6.45E-8	Crohn's disease	
ESCA	cis	1	rs2345001	chr5:150266518	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.53	-5.58	9.92E-8	Type 2 diabetes	
ESCA	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.52	-5.55	1.16E-7	Type 2 diabetes	
ESCA	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.75	-9.92	2.33E-18	Homocysteine levels	
ESCA	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.61	-8.02	2.18E-13	Homocysteine levels	
ESCA	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.62	-4.89	2.44E-6	Plasma clusterin levels	
ESCA	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.45	5.34	3.11E-7	Height	
ESCA	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.46	5.54	1.24E-7	Height	
ESCA	cis	1	rs2370642	chr3:134222136	ANAPC13	chr3:134196547-134204865:-	0.46	5.58	1.01E-7	Height	
ESCA	cis	1	rs2373865	chr3:134291556	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.03	1.33E-6	Height	
ESCA	cis	1	rs2404740	chr15:76852143	SCAPER	chr15:76640529-77197744:-	-0.38	-4.41	1.87E-5	Blood metabolite levels	
ESCA	cis	1	rs2404741	chr15:76851735	SCAPER	chr15:76640529-77197744:-	-0.38	-4.41	1.87E-5	Blood metabolite levels	
ESCA	cis	1	rs2420168	chr7:65630631	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.04E-7	Aortic root size	
ESCA	cis	1	rs2420591	chr7:65912381	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5.04	1.23E-6	Aortic root size	
ESCA	cis	1	rs2420820	chr7:66091907	NCRNA00174	chr7:65841032-65865395:-	0.4	4.61	8.36E-6	Aortic root size	
ESCA	cis	1	rs2420824	chr7:66131116	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.15E-7	Aortic root size	
ESCA	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.75	7.62	2.12E-12	Type 2 diabetes	
ESCA	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.61	4.74	4.82E-6	Tumor biomarkers	
ESCA	cis	1	rs2447196	chr15:43893818	CATSPER2	chr15:43922774-43959900:-	0.69	7.35	1.01E-11	Tumor biomarkers	
ESCA	cis	1	rs2447208	chr15:43933895	ADAL	chr15:43622872-43646094:+	-0.58	-4.71	5.35E-6	Tumor biomarkers	
ESCA	cis	1	rs2447208	chr15:43933895	CATSPER2	chr15:43922774-43959900:-	-0.64	-6.97	7.93E-11	Tumor biomarkers	
ESCA	cis	1	rs2447211	chr15:43936351	ADAL	chr15:43622872-43646094:+	-0.6	-4.81	3.5E-6	Tumor biomarkers	
ESCA	cis	1	rs2447211	chr15:43936351	CATSPER2	chr15:43922774-43959900:-	-0.64	-7.02	6.11E-11	Tumor biomarkers	
ESCA	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.31	4.41	1.88E-5	Homocysteine levels	
ESCA	cis	1	rs2448707	chr6:49446951	MUT	chr6:49398994-49431031:-	-0.45	-4.7	5.6E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.49	-6.45	1.26E-9	Ankylosing spondylitis	
ESCA	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.57	6.7	3.42E-10	Ankylosing spondylitis	
ESCA	cis	1	rs2470134	chr15:43849886	ADAL	chr15:43622872-43646094:+	0.63	4.86	2.81E-6	Tumor biomarkers	
ESCA	cis	1	rs2470134	chr15:43849886	CATSPER2	chr15:43922774-43959900:-	0.56	5.52	1.36E-7	Tumor biomarkers	
ESCA	cis	1	rs2486447	chr1:46545724	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs2501962	chr6:49453636	MUT	chr6:49398994-49431031:-	-0.45	-4.78	3.91E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs2501963	chr6:49454281	MUT	chr6:49398994-49431031:-	-0.45	-4.76	4.27E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.47	4.3	3.01E-5	Bipolar disorder and schizophrenia	
ESCA	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	0.7	6.62	5.29E-10	Type 2 diabetes	
ESCA	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	0.69	6.34	2.31E-9	Type 2 diabetes	
ESCA	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.75	7.72	1.23E-12	Type 2 diabetes	
ESCA	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.71	7.28	1.48E-11	Type 2 diabetes	
ESCA	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.74	7.48	4.76E-12	Type 2 diabetes	
ESCA	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	0.79	6.97	8.2E-11	Type 2 diabetes	
ESCA	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.78	-8.09	1.43E-13	Type 2 diabetes	
ESCA	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.76	7.73	1.18E-12	Type 2 diabetes	
ESCA	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.75	7.58	2.71E-12	Type 2 diabetes	
ESCA	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.76	7.73	1.12E-12	Type 2 diabetes	
ESCA	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.76	7.61	2.23E-12	Type 2 diabetes	
ESCA	cis	1	rs2533288	chr7:66056711	CRCP	chr7:65579805-65619551:+	-0.56	-4.26	3.51E-5	Diabetic kidney disease	
ESCA	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.76	7.65	1.8E-12	Type 2 diabetes	
ESCA	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.76	7.65	1.8E-12	Type 2 diabetes	
ESCA	cis	1	rs2608216	chr11:93149172	CCDC67	chr11:93063156-93171634:+	-0.47	-4.68	6.13E-6	Pulmonary function decline	
ESCA	cis	1	rs2614811	chr15:43913487	ADAL	chr15:43622872-43646094:+	-0.59	-4.42	1.8E-5	Tumor biomarkers	
ESCA	cis	1	rs2614811	chr15:43913487	CATSPER2	chr15:43922774-43959900:-	-0.7	-7.2	2.24E-11	Tumor biomarkers	
ESCA	cis	1	rs2617170	chr12:10560957	KLRC2	chr12:10579193-10588592:-	-0.36	-4.66	6.79E-6	Behcet's disease	
ESCA	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.49	-6.45	1.26E-9	Ankylosing spondylitis	
ESCA	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.57	6.7	3.42E-10	Ankylosing spondylitis	
ESCA	cis	1	rs2655310	chr4:130017919	C4orf33	chr4:130014829-130033842:+	-0.5	-6.74	2.77E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs2658778	chr11:93148948	CCDC67	chr11:93063156-93171634:+	-0.46	-4.51	1.24E-5	Pulmonary function decline	
ESCA	cis	1	rs2658779	chr11:93163137	CCDC67	chr11:93063156-93171634:+	0.48	4.69	5.88E-6	Pulmonary function decline	
ESCA	cis	1	rs2658781	chr11:93166368	CCDC67	chr11:93063156-93171634:+	0.47	4.57	9.72E-6	Pulmonary function decline	
ESCA	cis	1	rs2658782	chr11:93166731	CCDC67	chr11:93063156-93171634:+	-0.45	-4.34	2.53E-5	Pulmonary function decline	
ESCA	cis	1	rs2659889	chr7:66217112	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5.11	9.18E-7	Aortic root size	
ESCA	cis	1	rs2659906	chr7:66165310	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.24E-7	Aortic root size	
ESCA	cis	1	rs2659909	chr7:66160279	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.24E-7	Aortic root size	
ESCA	cis	1	rs2659912	chr7:66157999	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.15	7.67E-7	Aortic root size	
ESCA	cis	1	rs2659915	chr7:66153101	NCRNA00174	chr7:65841032-65865395:-	-0.45	-5.49	1.54E-7	Aortic root size	
ESCA	cis	1	rs2707831	chr7:66062511	CRCP	chr7:65579805-65619551:+	-0.56	-4.26	3.51E-5	Diabetic kidney disease	
ESCA	cis	1	rs2707836	chr7:66160435	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.24E-7	Aortic root size	
ESCA	cis	1	rs2707844	chr7:66059509	CRCP	chr7:65579805-65619551:+	-0.56	-4.26	3.51E-5	Diabetic kidney disease	
ESCA	cis	1	rs2707845	chr7:66198798	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.14	7.94E-7	Aortic root size	
ESCA	cis	1	rs2707850	chr7:66203870	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5.13	8.41E-7	Aortic root size	
ESCA	cis	1	rs2707854	chr7:66212597	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5.13	8.41E-7	Aortic root size	
ESCA	cis	1	rs2707856	chr7:66211010	NCRNA00174	chr7:65841032-65865395:-	-0.44	-5.33	3.27E-7	Aortic root size	
ESCA	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.51	-6.96	8.39E-11	Ankylosing spondylitis	
ESCA	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.58	6.99	7.03E-11	Ankylosing spondylitis	
ESCA	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.49	6.53	8.4E-10	Ankylosing spondylitis	
ESCA	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.56	-6.55	7.63E-10	Ankylosing spondylitis	
ESCA	cis	1	rs280603	chr4:129915063	C4orf33	chr4:130014829-130033842:+	-0.47	-6.55	7.53E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs280604	chr4:129921170	C4orf33	chr4:130014829-130033842:+	-0.48	-6.57	6.95E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.8	-11.06	1.86E-21	Response to antipsychotic treatment	
ESCA	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.79	-10.8	9.97E-21	Response to antipsychotic treatment	
ESCA	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.8	-11.06	1.86E-21	Response to antipsychotic treatment	
ESCA	cis	1	rs28365850	chr14:35591316	PPP2R3C	chr14:35554679-35591679:-	0.51	4.35	2.47E-5	Atopic dermatitis	
ESCA	cis	1	rs28396304	chr19:12081484	ZNF763	chr19:12035900-12091196:+	-0.59	-4.56	1.01E-5	Multiple sclerosis	
ESCA	cis	1	rs28409322	chr3:134252385	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.46	5.04	1.27E-6	Forced vital capacity	
ESCA	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.44	4.85	2.98E-6	Forced vital capacity	
ESCA	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.46	-5.13	8.25E-7	Forced vital capacity	
ESCA	cis	1	rs28655955	chr19:12064771	ZNF763	chr19:12035900-12091196:+	-0.67	-5.02	1.34E-6	Multiple sclerosis	
ESCA	cis	1	rs2869548	chr15:78922638	CHRNA3	chr15:78885397-78913322:-	-0.45	-4.3	2.96E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.71	7.64	1.95E-12	Diastolic blood pressure	
ESCA	cis	1	rs2874490	chr3:156635513	LEKR1	chr3:156544076-156763918:+	-0.45	-4.28	3.25E-5	Bone mineral density	
ESCA	cis	1	rs2880791	chr5:150267376	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.46	5.5	1.46E-7	Height	
ESCA	cis	1	rs2896954	chr15:76851692	SCAPER	chr15:76640529-77197744:-	-0.37	-4.24	3.74E-5	Blood metabolite levels	
ESCA	cis	1	rs2901438	chr2:73665656	ALMS1P	chr2:73872046-73912692:+	0.42	4.3	2.98E-5	Metabolite levels	
ESCA	cis	1	rs2920781	chr15:43924682	ADAL	chr15:43622872-43646094:+	-0.6	-4.71	5.38E-6	Tumor biomarkers	
ESCA	cis	1	rs2920781	chr15:43924682	CATSPER2	chr15:43922774-43959900:-	-0.64	-6.75	2.63E-10	Tumor biomarkers	
ESCA	cis	1	rs2927072	chr15:43922398	ADAL	chr15:43622872-43646094:+	-0.57	-4.33	2.59E-5	Tumor biomarkers	
ESCA	cis	1	rs2927072	chr15:43922398	CATSPER2	chr15:43922774-43959900:-	-0.69	-7.12	3.44E-11	Tumor biomarkers	
ESCA	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.77	-9.74	6.94E-18	Homocysteine levels	
ESCA	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.49	-6.45	1.26E-9	Ankylosing spondylitis	
ESCA	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.57	6.7	3.42E-10	Ankylosing spondylitis	
ESCA	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.51	-6.89	1.21E-10	Ankylosing spondylitis	
ESCA	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.56	6.72	3.07E-10	Ankylosing spondylitis	
ESCA	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.51	-6.89	1.21E-10	Ankylosing spondylitis	
ESCA	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.56	6.72	3.07E-10	Ankylosing spondylitis	
ESCA	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.51	-6.89	1.21E-10	Ankylosing spondylitis	
ESCA	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.56	6.72	3.07E-10	Ankylosing spondylitis	
ESCA	cis	1	rs3091242	chr1:25674785	RHD	chr1:25598981-25656935:+	-0.4	-4.62	7.73E-6	Erythrocyte sedimentation rate	
ESCA	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	0.75	7.53	3.61E-12	Type 2 diabetes	
ESCA	cis	1	rs3099899	chr4:129917368	C4orf33	chr4:130014829-130033842:+	-0.48	-6.57	6.95E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.59	-4.42	1.8E-5	Tumor biomarkers	
ESCA	cis	1	rs3101443	chr15:43912372	CATSPER2	chr15:43922774-43959900:-	-0.7	-7.2	2.24E-11	Tumor biomarkers	
ESCA	cis	1	rs3105369	chr4:130022448	C4orf33	chr4:130014829-130033842:+	-0.51	-6.87	1.39E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs3110496	chr17:27917771	TP53I13	chr17:27895739-27900174:+	0.35	4.72	5.15E-6	Height	
ESCA	cis	1	rs3113489	chr4:129961179	C4orf33	chr4:130014829-130033842:+	-0.47	-6.1	7.67E-9	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.84	-6.12	7.03E-9	Dental caries	
ESCA	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	0.72	6.75	2.69E-10	Type 2 diabetes	
ESCA	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.75	7.55	3.18E-12	Type 2 diabetes	
ESCA	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	0.74	7.46	5.18E-12	Type 2 diabetes	
ESCA	cis	1	rs34102169	chr1:46424864	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.56	1.03E-5	Body mass index	
ESCA	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.65	-7.6	2.37E-12	Response to antipsychotic treatment	
ESCA	cis	1	rs34128973	chr11:47851376	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.22	6.77E-22	Subjective well-being	
ESCA	cis	1	rs34156253	chr5:150226230	LOC134466	chr5:150310000-150326146:-	0.54	5.12	8.81E-7	Crohn's disease	
ESCA	cis	1	rs342292	chr7:106370644	BCAP29	chr7:107220422-107263762:+	-0.37	-4.53	1.15E-5	Mean platelet volume	
ESCA	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.6	-6.8	2.04E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs344081	chr3:156555984	LEKR1	chr3:156544076-156763918:+	-0.45	-4.35	2.39E-5	Bone mineral density	
ESCA	cis	1	rs344088	chr3:156561361	LEKR1	chr3:156544076-156763918:+	-0.46	-4.55	1.08E-5	Bone mineral density	
ESCA	cis	1	rs344090	chr3:156563140	LEKR1	chr3:156544076-156763918:+	-0.46	-4.55	1.08E-5	Bone mineral density	
ESCA	cis	1	rs34409160	chr2:28943865	TRMT61B	chr2:29072690-29093175:-	0.34	4.29	3.13E-5	Body mass index	
ESCA	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.6	-6.8	2.04E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.63	-7.39	8.0E-12	Response to antipsychotic treatment	
ESCA	cis	1	rs34684276	chr15:78813155	CHRNA3	chr15:78885397-78913322:-	-0.47	-4.54	1.1E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio;Nicotine dependence	
ESCA	cis	1	rs34684276	chr15:78813155	CHRNA5	chr15:78857906-78886458:+	-0.45	-4.61	8.35E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio;Nicotine dependence	
ESCA	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.65	-7.61	2.33E-12	Response to antipsychotic treatment	
ESCA	cis	1	rs34910028	chr11:47758449	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.18	8.91E-22	Subjective well-being	
ESCA	cis	1	rs34949904	chr22:24695298	POM121L9P	chr22:24647589-24661490:+	-0.45	-5.82	3.12E-8	Gut microbiome composition (summer)	
ESCA	cis	1	rs35006492	chr4:129878342	C4orf33	chr4:130014829-130033842:+	0.47	6.72	3.0E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.46	-5.1	9.46E-7	Forced vital capacity	
ESCA	cis	1	rs35146655	chr22:24605938	SUSD2	chr22:24577444-24585074:+	0.79	5.05	1.2E-6	Amyotrophic lateral sclerosis	
ESCA	cis	1	rs35149210	chr7:65929925	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5	1.5E-6	Aortic root size	
ESCA	cis	1	rs35303215	chr22:24801535	POM121L9P	chr22:24647589-24661490:+	-0.44	-5.69	6.06E-8	Gut microbiome composition (summer)	
ESCA	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.8	-11.06	1.86E-21	Response to antipsychotic treatment	
ESCA	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.6	-6.8	2.04E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.27	4.48	1.43E-5	Eye color traits	
ESCA	cis	1	rs35624992	chr11:47615798	C1QTNF4	chr11:47611216-47615961:-	-0.62	-10.63	2.86E-20	Subjective well-being	
ESCA	cis	1	rs35718987	chr3:134272783	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.8	-11.06	1.86E-21	Response to antipsychotic treatment	
ESCA	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.59	-6.6	5.81E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.63	-7.2	2.24E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs35902101	chr11:47795169	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.18	8.91E-22	Subjective well-being	
ESCA	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.63	-7.2	2.24E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs36216559	chr2:262335	SH3YL1	chr2:218138-264810:-	-0.6	-8.05	1.78E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs3735148	chr7:65971009	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs3738848	chr2:73761881	ALMS1P	chr2:73872046-73912692:+	0.43	4.28	3.21E-5	Metabolite levels	
ESCA	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.53	-7.9	4.25E-13	IgG glycosylation	
ESCA	cis	1	rs3747113	chr22:24717518	POM121L9P	chr22:24647589-24661490:+	0.46	6.42	1.49E-9	Gut microbiome composition (summer)	
ESCA	cis	1	rs3761959	chr1:157669278	FCRL3	chr1:157646278-157670775:-	0.32	5.57	1.07E-7	Type 1 diabetes autoantibodies	
ESCA	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.78	8.44	1.83E-14	Diastolic blood pressure	
ESCA	cis	1	rs3778909	chr7:66255646	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.15	7.53E-7	Aortic root size	
ESCA	cis	1	rs3782894	chr12:110026024	MMAB	chr12:109991523-110011358:-	-0.36	-4.93	2.07E-6	HDL cholesterol	
ESCA	cis	1	rs3791220	chr2:227066	SH3YL1	chr2:218138-264810:-	-0.6	-7.81	7.26E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs3791221	chr2:226933	SH3YL1	chr2:218138-264810:-	-0.59	-7.64	1.93E-12	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs3791223	chr2:222336	SH3YL1	chr2:218138-264810:-	-0.6	-7.8	7.64E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs3791224	chr2:221981	SH3YL1	chr2:218138-264810:-	-0.6	-7.8	7.64E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs3800812	chr7:66223461	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5.13	8.41E-7	Aortic root size	
ESCA	cis	1	rs3806988	chr6:49431569	MUT	chr6:49398994-49431031:-	0.47	5.29	3.96E-7	Folate pathway vitamin levels	
ESCA	cis	1	rs3813227	chr2:73651967	ALMS1P	chr2:73872046-73912692:+	-0.42	-4.35	2.43E-5	Metabolite levels	
ESCA	cis	1	rs3823114	chr6:49431720	MUT	chr6:49398994-49431031:-	0.46	4.93	2.1E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs3828165	chr2:220889	SH3YL1	chr2:218138-264810:-	-0.6	-7.8	7.64E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.46	5.5	1.46E-7	Height	
ESCA	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.46	5.6	9.31E-8	Height	
ESCA	cis	1	rs3857422	chr5:150268609	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs3857688	chr7:66127806	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.15E-7	Aortic root size	
ESCA	cis	1	rs3900064	chr5:150264414	LOC134466	chr5:150310000-150326146:-	-0.61	-5.82	3.2E-8	Crohn's disease	
ESCA	cis	1	rs3906527	chr5:150266392	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs3906528	chr5:150266718	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs391396	chr4:130037653	C4orf33	chr4:130014829-130033842:+	-0.48	-6.48	1.11E-9	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs3931020	chr1:75235317	CRYZ	chr1:75171175-75199092:-	-0.45	-4.92	2.17E-6	Resistin levels	
ESCA	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.46	5.57	1.05E-7	Height	
ESCA	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.27	4.48	1.43E-5	Eye color traits	
ESCA	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.53	-5.58	9.92E-8	Type 2 diabetes	
ESCA	cis	1	rs3981131	chr7:65951677	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.12	8.66E-7	Aortic root size	
ESCA	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.4	-5.31	3.71E-7	Inflammatory skin disease	
ESCA	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.62	7.9	4.4E-13	Inflammatory skin disease	
ESCA	cis	1	rs4073846	chr1:46462881	CCDC163P	chr1:45960581-45965646:-	0.35	4.29	3.05E-5	Body mass index	
ESCA	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.26	-4.36	2.32E-5	Eye color traits	
ESCA	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.27	-4.52	1.22E-5	Eye color traits	
ESCA	cis	1	rs4076006	chr1:46438076	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.62	7.93E-6	Body mass index	
ESCA	cis	1	rs4134386	chr1:46395089	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.4	1.98E-5	Body mass index	
ESCA	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.45	4.94	1.99E-6	Forced vital capacity	
ESCA	cis	1	rs4267943	chr6:49439805	MUT	chr6:49398994-49431031:-	-0.42	-4.37	2.2E-5	Folate pathway vitamin levels	
ESCA	cis	1	rs4279493	chr7:66226620	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5.13	8.41E-7	Aortic root size	
ESCA	cis	1	rs4282209	chr4:76919536	NAAA	chr4:76831809-76862166:-	-0.34	-4.28	3.17E-5	Longevity	
ESCA	cis	1	rs4309773	chr3:134277301	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	0.74	7.46	5.18E-12	Type 2 diabetes	
ESCA	cis	1	rs4334685	chr3:134304335	ANAPC13	chr3:134196547-134204865:-	0.44	5.33	3.36E-7	Height	
ESCA	cis	1	rs4367113	chr3:134287975	ANAPC13	chr3:134196547-134204865:-	0.44	5.3	3.88E-7	Height	
ESCA	cis	1	rs4368544	chr3:134300014	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.03	1.33E-6	Height	
ESCA	cis	1	rs4372836	chr2:28973883	TRMT61B	chr2:29072690-29093175:-	-0.35	-4.36	2.35E-5	Body mass index	
ESCA	cis	1	rs4376778	chr1:46288846	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.53	1.13E-5	Body mass index	
ESCA	cis	1	rs439295	chr3:156572455	LEKR1	chr3:156544076-156763918:+	-0.46	-4.55	1.08E-5	Bone mineral density	
ESCA	cis	1	rs4394010	chr4:129894649	C4orf33	chr4:130014829-130033842:+	0.48	6.76	2.42E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs4417907	chr3:134291363	ANAPC13	chr3:134196547-134204865:-	0.44	5.27	4.28E-7	Height	
ESCA	cis	1	rs4423809	chr3:134300107	ANAPC13	chr3:134196547-134204865:-	-0.44	-5.24	5.08E-7	Height	
ESCA	cis	1	rs4466058	chr4:129923879	C4orf33	chr4:130014829-130033842:+	-0.47	-6.28	3.12E-9	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs4469291	chr6:49440614	MUT	chr6:49398994-49431031:-	0.45	4.7	5.6E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs4497901	chr2:239969	SH3YL1	chr2:218138-264810:-	-0.59	-7.58	2.65E-12	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.46	5.35	2.97E-7	Height	
ESCA	cis	1	rs4535272	chr3:134299916	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.03	1.33E-6	Height	
ESCA	cis	1	rs4545281	chr1:46360054	CCDC163P	chr1:45960581-45965646:-	-0.34	-4.43	1.71E-5	Body mass index	
ESCA	cis	1	rs4549034	chr2:28972579	TRMT61B	chr2:29072690-29093175:-	-0.35	-4.36	2.35E-5	Body mass index	
ESCA	cis	1	rs4560537	chr5:150262586	LOC134466	chr5:150310000-150326146:-	0.57	5.67	6.45E-8	Crohn's disease	
ESCA	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.3	4.29	3.04E-5	Hematology traits	
ESCA	cis	1	rs4572812	chr3:134291177	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.03	1.33E-6	Height	
ESCA	cis	1	rs4579248	chr5:150268151	LOC134466	chr5:150310000-150326146:-	0.55	5.04	1.28E-6	Crohn's disease	
ESCA	cis	1	rs4640348	chr2:28965479	TRMT61B	chr2:29072690-29093175:-	-0.35	-4.36	2.35E-5	Body mass index	
ESCA	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.76	10.45	8.63E-20	Homocysteine levels	
ESCA	cis	1	rs4660317	chr1:46326226	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.67	6.45E-6	Body mass index	
ESCA	cis	1	rs4660319	chr1:46341623	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.67	6.45E-6	Body mass index	
ESCA	cis	1	rs4660321	chr1:46366760	CCDC163P	chr1:45960581-45965646:-	-0.35	-4.37	2.25E-5	Body mass index	
ESCA	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.64	-8.29	4.61E-14	Homocysteine levels	
ESCA	cis	1	rs4660898	chr1:46402171	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.4	1.98E-5	Body mass index	
ESCA	cis	1	rs4660910	chr1:46548402	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.77E-6	Body mass index	
ESCA	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.51	-6.89	1.21E-10	Ankylosing spondylitis	
ESCA	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.56	6.72	3.07E-10	Ankylosing spondylitis	
ESCA	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.79	-10.75	1.32E-20	Response to antipsychotic treatment	
ESCA	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.79	-10.76	1.22E-20	Response to antipsychotic treatment	
ESCA	cis	1	rs4715129	chr6:49415043	MUT	chr6:49398994-49431031:-	0.46	4.96	1.8E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs4715130	chr6:49416825	MUT	chr6:49398994-49431031:-	0.44	4.79	3.75E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs4717292	chr7:65895598	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5	1.5E-6	Aortic root size	
ESCA	cis	1	rs4717300	chr7:65947380	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5.02	1.36E-6	Aortic root size	
ESCA	cis	1	rs4717310	chr7:66161007	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.14	7.92E-7	Aortic root size	
ESCA	cis	1	rs4717319	chr7:66242593	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5.13	8.41E-7	Aortic root size	
ESCA	cis	1	rs4718307	chr7:65610988	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.04E-7	Aortic root size	
ESCA	cis	1	rs4718343	chr7:65874288	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs4718344	chr7:65874381	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs4718357	chr7:65960878	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs4752797	chr11:47874364	C1QTNF4	chr11:47611216-47615961:-	-0.66	-10.95	3.74E-21	Subjective well-being	
ESCA	cis	1	rs4752856	chr11:47648042	C1QTNF4	chr11:47611216-47615961:-	-0.61	-10.34	1.71E-19	Subjective well-being	
ESCA	cis	1	rs4752857	chr11:47655752	C1QTNF4	chr11:47611216-47615961:-	-0.65	-11.06	1.9E-21	Subjective well-being	
ESCA	cis	1	rs4752873	chr11:47857520	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.28	4.71E-22	Subjective well-being	
ESCA	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.44	-4.88	2.6E-6	Forced vital capacity	
ESCA	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.54	-6.94	9.28E-11	Cognitive function	
ESCA	cis	1	rs4794202	chr17:45930539	SCRN2	chr17:45915049-45918699:-	-0.73	-5.94	1.71E-8	Alzheimer's disease (cognitive decline)	
ESCA	cis	1	rs4803774	chr19:45450872	APOC1	chr19:45417577-45422606:+	0.3	4.32	2.78E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
ESCA	cis	1	rs4859582	chr4:76907213	NAAA	chr4:76831809-76862166:-	-0.34	-4.33	2.58E-5	Longevity	
ESCA	cis	1	rs4862406	chr4:185629339	MLF1IP	chr4:185615220-185655286:-	0.5	6.1	7.72E-9	Kawasaki disease	
ESCA	cis	1	rs486301	chr15:43836949	ADAL	chr15:43622872-43646094:+	-0.57	-5.08	1.05E-6	Tumor biomarkers	
ESCA	cis	1	rs486301	chr15:43836949	CATSPER2	chr15:43922774-43959900:-	-0.43	-4.77	4.2E-6	Tumor biomarkers	
ESCA	cis	1	rs4869313	chr5:96223880	ERAP1	chr5:96096515-96149837:-	0.35	4.6	8.62E-6	Pediatric autoimmune diseases	
ESCA	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-0.95	-18.34	4.43E-41	Pediatric autoimmune diseases	
ESCA	cis	1	rs4887067	chr15:78886947	CHRNA3	chr15:78885397-78913322:-	-0.49	-4.74	4.82E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs4887067	chr15:78886947	CHRNA5	chr15:78857906-78886458:+	-0.45	-4.6	8.5E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs4903201	chr14:74659690	LIN52	chr14:74551656-74667117:+	-0.3	-4.25	3.69E-5	Common traits (Other)	
ESCA	cis	1	rs4903202	chr14:74660302	LIN52	chr14:74551656-74667117:+	-0.32	-4.43	1.77E-5	Common traits (Other)	
ESCA	cis	1	rs4903203	chr14:74660508	LIN52	chr14:74551656-74667117:+	-0.32	-4.43	1.77E-5	Common traits (Other)	
ESCA	cis	1	rs4919690	chr10:104616500	C10orf32	chr10:104613967-104624718:+	0.59	6.27	3.34E-9	Arsenic metabolism	
ESCA	cis	1	rs4925540	chr1:247214878	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.1E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs4932143	chr15:90372067	AP3S2	chr15:90373832-90456222:-	-0.58	-6.44	1.33E-9	Type 2 diabetes	
ESCA	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.55	-6.36	2.1E-9	Type 2 diabetes	
ESCA	cis	1	rs4955485	chr3:134295843	ANAPC13	chr3:134196547-134204865:-	0.44	5.35	3.0E-7	Height	
ESCA	cis	1	rs4955555	chr3:134286427	ANAPC13	chr3:134196547-134204865:-	0.44	5.3	3.88E-7	Height	
ESCA	cis	1	rs4958424	chr5:150225036	LOC134466	chr5:150310000-150326146:-	0.54	5.12	8.81E-7	Crohn's disease	
ESCA	cis	1	rs4958426	chr5:150278346	LOC134466	chr5:150310000-150326146:-	0.55	5.04	1.28E-6	Crohn's disease	
ESCA	cis	1	rs4958842	chr5:150224877	LOC134466	chr5:150310000-150326146:-	0.58	5.03	1.29E-6	Crohn's disease	
ESCA	cis	1	rs4958843	chr5:150224924	LOC134466	chr5:150310000-150326146:-	0.54	5.12	8.81E-7	Crohn's disease	
ESCA	cis	1	rs4958848	chr5:150271122	LOC134466	chr5:150310000-150326146:-	0.54	5.24	5.13E-7	Crohn's disease	
ESCA	cis	1	rs496584	chr15:43831923	ADAL	chr15:43622872-43646094:+	-0.56	-4.98	1.62E-6	Tumor biomarkers	
ESCA	cis	1	rs496584	chr15:43831923	CATSPER2	chr15:43922774-43959900:-	-0.41	-4.57	9.9E-6	Tumor biomarkers	
ESCA	cis	1	rs4971316	chr1:247210903	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.1E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs4971319	chr1:247211565	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.1E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs4974483	chr3:134219001	ANAPC13	chr3:134196547-134204865:-	0.46	5.54	1.24E-7	Height	
ESCA	cis	1	rs4974484	chr3:134219019	ANAPC13	chr3:134196547-134204865:-	0.45	5.42	2.17E-7	Height	
ESCA	cis	1	rs4974493	chr3:134219993	ANAPC13	chr3:134196547-134204865:-	0.46	5.58	1.01E-7	Height	
ESCA	cis	1	rs4975193	chr4:129980630	C4orf33	chr4:130014829-130033842:+	-0.47	-6.14	6.5E-9	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs4975194	chr4:129982377	C4orf33	chr4:130014829-130033842:+	-0.46	-5.87	2.49E-8	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs55753056	chr2:243929	SH3YL1	chr2:218138-264810:-	-0.6	-7.71	1.31E-12	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs55835850	chr2:28949296	TRMT61B	chr2:29072690-29093175:-	0.34	4.29	3.13E-5	Body mass index	
ESCA	cis	1	rs55913793	chr3:134285968	ANAPC13	chr3:134196547-134204865:-	0.44	5.3	3.88E-7	Height	
ESCA	cis	1	rs55936726	chr2:258210	SH3YL1	chr2:218138-264810:-	-0.6	-8.05	1.78E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs55946380	chr2:268293	SH3YL1	chr2:218138-264810:-	-0.6	-8.05	1.78E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs55962648	chr7:65625751	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.04E-7	Aortic root size	
ESCA	cis	1	rs56077333	chr15:78899003	CHRNA5	chr15:78857906-78886458:+	-0.45	-5.36	2.92E-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.71	7.64	1.95E-12	Diastolic blood pressure	
ESCA	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.71	7.64	1.95E-12	Diastolic blood pressure	
ESCA	cis	1	rs56167434	chr2:282137	SH3YL1	chr2:218138-264810:-	-0.63	-8.44	1.82E-14	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs56321614	chr2:268191	SH3YL1	chr2:218138-264810:-	-0.61	-8.02	2.13E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs56326127	chr2:86212201	POLR1A	chr2:86253453-86333278:-	-0.51	-4.97	1.75E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
ESCA	cis	1	rs56390833	chr15:78877381	CHRNA3	chr15:78885397-78913322:-	-0.44	-4.27	3.37E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.48	-7.24	1.86E-11	Crohn's disease	
ESCA	cis	1	rs56884994	chr1:247211057	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.1E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs56977454	chr2:86204014	POLR1A	chr2:86253453-86333278:-	-0.45	-4.32	2.73E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
ESCA	cis	1	rs57001853	chr5:150272452	LOC134466	chr5:150310000-150326146:-	0.54	5.24	5.13E-7	Crohn's disease	
ESCA	cis	1	rs57075379	chr14:35577801	PPP2R3C	chr14:35554679-35591679:-	0.53	4.59	8.97E-6	Atopic dermatitis	
ESCA	cis	1	rs57542652	chr2:228088	SH3YL1	chr2:218138-264810:-	-0.59	-7.64	1.93E-12	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs5760216	chr22:24539734	SUSD2	chr22:24577444-24585074:+	0.92	5.27	4.44E-7	Amyotrophic lateral sclerosis	
ESCA	cis	1	rs5760220	chr22:24542480	SUSD2	chr22:24577444-24585074:+	0.92	5.27	4.44E-7	Amyotrophic lateral sclerosis	
ESCA	cis	1	rs5760229	chr22:24560254	SUSD2	chr22:24577444-24585074:+	0.92	5.27	4.44E-7	Amyotrophic lateral sclerosis	
ESCA	cis	1	rs58088385	chr20:33748229	MAP1LC3A	chr20:33134692-33148149:+	0.56	4.25	3.64E-5	Anticoagulant levels;D-dimer levels;Protein C levels;Factor VII levels;Hemostatic factors and hematological phenotypes	
ESCA	cis	1	rs58336952	chr19:12057916	ZNF763	chr19:12035900-12091196:+	-0.63	-4.78	3.88E-6	Multiple sclerosis	
ESCA	cis	1	rs58365138	chr2:86213105	POLR1A	chr2:86253453-86333278:-	-0.51	-4.97	1.75E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
ESCA	cis	1	rs58461606	chr2:267367	SH3YL1	chr2:218138-264810:-	-0.6	-8.05	1.78E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs58717741	chr5:150284936	LOC134466	chr5:150310000-150326146:-	0.53	4.84	3.04E-6	Crohn's disease	
ESCA	cis	1	rs59043558	chr5:150334662	LOC134466	chr5:150310000-150326146:-	0.58	5.22	5.5E-7	Crohn's disease	
ESCA	cis	1	rs59531858	chr5:150247063	LOC134466	chr5:150310000-150326146:-	0.6	5.47	1.73E-7	Crohn's disease	
ESCA	cis	1	rs59937473	chr2:271797	SH3YL1	chr2:218138-264810:-	-0.6	-8.05	1.78E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs59980321	chr5:150241813	LOC134466	chr5:150310000-150326146:-	0.55	5.36	2.93E-7	Crohn's disease	
ESCA	cis	1	rs60134818	chr5:150261043	LOC134466	chr5:150310000-150326146:-	0.55	5.32	3.52E-7	Crohn's disease	
ESCA	cis	1	rs60149603	chr2:285421	SH3YL1	chr2:218138-264810:-	-0.61	-8.14	1.11E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs6037562	chr20:3326141	ITPA	chr20:3190056-3204504:+	-0.4	-4.3	3.02E-5	IFN-related cytopenia	
ESCA	cis	1	rs6037567	chr20:3332160	ITPA	chr20:3190056-3204504:+	-0.4	-4.3	3.02E-5	IFN-related cytopenia	
ESCA	cis	1	rs60484953	chr2:221560	SH3YL1	chr2:218138-264810:-	-0.6	-7.8	7.64E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs6051753	chr20:3315513	ITPA	chr20:3190056-3204504:+	-0.41	-4.27	3.31E-5	IFN-related cytopenia	
ESCA	cis	1	rs6051764	chr20:3321807	ITPA	chr20:3190056-3204504:+	0.43	4.63	7.57E-6	IFN-related cytopenia	
ESCA	cis	1	rs6051779	chr20:3333449	ITPA	chr20:3190056-3204504:+	-0.4	-4.34	2.52E-5	IFN-related cytopenia	
ESCA	cis	1	rs6051827	chr20:3372007	ITPA	chr20:3190056-3204504:+	-0.4	-4.25	3.64E-5	IFN-related cytopenia	
ESCA	cis	1	rs60697554	chr19:12057759	ZNF763	chr19:12035900-12091196:+	-0.63	-4.78	3.88E-6	Multiple sclerosis	
ESCA	cis	1	rs60843830	chr2:286756	SH3YL1	chr2:218138-264810:-	-0.59	-7.14	3.17E-11	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs60982898	chr6:49385806	MUT	chr6:49398994-49431031:-	0.48	5.11	9.08E-7	Folate pathway vitamin levels	
ESCA	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.48	-5.23	5.28E-7	Forced vital capacity	
ESCA	cis	1	rs61102033	chr1:46382441	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.47	1.5E-5	Body mass index	
ESCA	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.98	-8.4	2.39E-14	Triglycerides	
ESCA	cis	1	rs61270113	chr5:150226263	LOC134466	chr5:150310000-150326146:-	0.54	5.12	8.81E-7	Crohn's disease	
ESCA	cis	1	rs6139088	chr20:3329063	ITPA	chr20:3190056-3204504:+	-0.4	-4.3	3.02E-5	IFN-related cytopenia	
ESCA	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-0.87	-4.87	2.64E-6	Blood metabolite levels	
ESCA	cis	1	rs61530785	chr5:150261364	LOC134466	chr5:150310000-150326146:-	0.56	5.25	4.79E-7	Crohn's disease	
ESCA	cis	1	rs61783200	chr1:46297403	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.53	1.13E-5	Body mass index	
ESCA	cis	1	rs61783220	chr1:46335312	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.67	6.45E-6	Body mass index	
ESCA	cis	1	rs61852630	chr1:247210193	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.1E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs61852637	chr1:247219636	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.11E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs62064224	chr17:30635115	TMEM98	chr17:31254928-31268665:+	-0.35	-4.24	3.75E-5	Schizophrenia	
ESCA	cis	1	rs62114497	chr2:214837	SH3YL1	chr2:218138-264810:-	-0.6	-7.7	1.36E-12	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs62114501	chr2:231741	SH3YL1	chr2:218138-264810:-	-0.59	-7.64	1.93E-12	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs62114505	chr2:242426	SH3YL1	chr2:218138-264810:-	-0.59	-7.58	2.65E-12	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs62114544	chr2:269679	SH3YL1	chr2:218138-264810:-	-0.6	-8.05	1.78E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs62114548	chr2:274672	SH3YL1	chr2:218138-264810:-	-0.6	-7.97	2.92E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.46	5.54	1.24E-7	Height	
ESCA	cis	1	rs62271513	chr3:134298412	ANAPC13	chr3:134196547-134204865:-	-0.44	-5.24	5.08E-7	Height	
ESCA	cis	1	rs62271514	chr3:134298554	ANAPC13	chr3:134196547-134204865:-	-0.44	-5.24	5.08E-7	Height	
ESCA	cis	1	rs62271515	chr3:134300507	ANAPC13	chr3:134196547-134204865:-	0.44	5.33	3.36E-7	Height	
ESCA	cis	1	rs62466793	chr7:66191517	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.2	6.04E-7	Aortic root size	
ESCA	cis	1	rs62466794	chr7:66191579	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.18	6.63E-7	Aortic root size	
ESCA	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.48	-7.24	1.86E-11	Crohn's disease	
ESCA	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.72	-9.58	1.87E-17	Homocysteine levels	
ESCA	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.63	-8.6	7.22E-15	Homocysteine levels	
ESCA	cis	1	rs6429582	chr1:46321843	CCDC163P	chr1:45960581-45965646:-	0.39	4.78	3.93E-6	Body mass index	
ESCA	cis	1	rs6439484	chr3:134249899	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs6439487	chr3:134260860	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs6441104	chr3:156681441	LEKR1	chr3:156544076-156763918:+	-0.51	-4.66	6.73E-6	Bone mineral density	
ESCA	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.72	7.43	6.13E-12	Type 2 diabetes	
ESCA	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.73	7.69	1.48E-12	Type 2 diabetes	
ESCA	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.8	11.27	5.0E-22	Response to antipsychotic treatment	
ESCA	cis	1	rs6458690	chr6:49411619	MUT	chr6:49398994-49431031:-	0.47	5.13	8.37E-7	Folate pathway vitamin levels	
ESCA	cis	1	rs6458694	chr6:49445306	MUT	chr6:49398994-49431031:-	0.45	4.7	5.6E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs6460292	chr7:65810075	NCRNA00174	chr7:65841032-65865395:-	0.42	5	1.53E-6	Aortic root size	
ESCA	cis	1	rs6460295	chr7:65882728	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs6460296	chr7:65895139	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5	1.5E-6	Aortic root size	
ESCA	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.43	-4.58	9.48E-6	Forced vital capacity	
ESCA	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.48	5.32	3.44E-7	Forced vital capacity	
ESCA	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.53	-5.64	7.67E-8	Type 2 diabetes	
ESCA	cis	1	rs6532078	chr4:76920809	NAAA	chr4:76831809-76862166:-	-0.34	-4.28	3.17E-5	Longevity	
ESCA	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.45	6.19	4.99E-9	Tuberculosis	
ESCA	cis	1	rs6546835	chr2:73664715	ALMS1P	chr2:73872046-73912692:+	0.42	4.3	2.98E-5	Metabolite levels	
ESCA	cis	1	rs6546836	chr2:73677833	ALMS1P	chr2:73872046-73912692:+	0.43	4.41	1.9E-5	Metabolite levels	
ESCA	cis	1	rs6546837	chr2:73677898	ALMS1P	chr2:73872046-73912692:+	0.42	4.34	2.55E-5	Metabolite levels	
ESCA	cis	1	rs6546838	chr2:73679280	ALMS1P	chr2:73872046-73912692:+	0.42	4.34	2.55E-5	Metabolite levels	
ESCA	cis	1	rs6546839	chr2:73680508	ALMS1P	chr2:73872046-73912692:+	0.42	4.34	2.55E-5	Metabolite levels	
ESCA	cis	1	rs6547872	chr2:28978074	TRMT61B	chr2:29072690-29093175:-	-0.36	-4.48	1.43E-5	Body mass index	
ESCA	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.48	-7.24	1.86E-11	Crohn's disease	
ESCA	cis	1	rs6570196	chr6:138264439	TNFAIP3	chr6:138188581-138204445:+	-0.44	-4.29	3.07E-5	Cardiac Troponin-T levels	
ESCA	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.93	-7.71	1.27E-12	Cholesterol, total	
ESCA	cis	1	rs6579803	chr5:150255559	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs6579804	chr5:150255931	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs6579806	chr5:150271084	LOC134466	chr5:150310000-150326146:-	0.54	5.24	5.13E-7	Crohn's disease	
ESCA	cis	1	rs6656992	chr1:46333068	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.67	6.45E-6	Body mass index	
ESCA	cis	1	rs6662641	chr1:46571509	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.77	-9.98	1.67E-18	Homocysteine levels	
ESCA	cis	1	rs6668284	chr1:46354510	CCDC163P	chr1:45960581-45965646:-	-0.35	-4.34	2.56E-5	Body mass index	
ESCA	cis	1	rs6669522	chr1:46397941	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.4	1.98E-5	Body mass index	
ESCA	cis	1	rs6672898	chr1:46290588	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.53	1.13E-5	Body mass index	
ESCA	cis	1	rs6675726	chr1:46560643	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs6675946	chr1:46371774	CCDC163P	chr1:45960581-45965646:-	-0.35	-4.37	2.25E-5	Body mass index	
ESCA	cis	1	rs6677007	chr1:46400590	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.4	1.98E-5	Body mass index	
ESCA	cis	1	rs6680380	chr1:46300189	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.53	1.13E-5	Body mass index	
ESCA	cis	1	rs6695809	chr1:46285461	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.53	1.15E-5	Body mass index	
ESCA	cis	1	rs6700597	chr1:46284246	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.34	2.55E-5	Body mass index	
ESCA	cis	1	rs6701614	chr1:46309420	CCDC163P	chr1:45960581-45965646:-	-0.39	-4.75	4.46E-6	Body mass index	
ESCA	cis	1	rs6707722	chr2:73654363	ALMS1P	chr2:73872046-73912692:+	0.42	4.3	2.98E-5	Metabolite levels	
ESCA	cis	1	rs6707848	chr2:28988083	TRMT61B	chr2:29072690-29093175:-	-0.36	-4.45	1.63E-5	Body mass index	
ESCA	cis	1	rs6708328	chr2:24412413	C2orf84	chr2:24397531-24414566:+	0.48	4.76	4.28E-6	Venous thromboembolism (SNP x SNP interaction)	
ESCA	cis	1	rs6709534	chr2:217334	SH3YL1	chr2:218138-264810:-	-0.6	-7.7	1.37E-12	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs6710438	chr2:73820108	ALMS1P	chr2:73872046-73912692:+	-0.42	-4.26	3.5E-5	Metabolite levels	
ESCA	cis	1	rs6711033	chr2:73746643	ALMS1P	chr2:73872046-73912692:+	0.43	4.29	3.14E-5	Metabolite levels	
ESCA	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.68	-4.23	3.89E-5	Rheumatoid arthritis	
ESCA	cis	1	rs6720809	chr2:88528943	THNSL2	chr2:88469835-88486145:+	-0.62	-4.58	9.31E-6	Plasma clusterin levels	
ESCA	cis	1	rs6722069	chr2:88533151	THNSL2	chr2:88469835-88486145:+	-0.61	-4.52	1.19E-5	Plasma clusterin levels	
ESCA	cis	1	rs6724782	chr2:73679990	ALMS1P	chr2:73872046-73912692:+	0.42	4.34	2.55E-5	Metabolite levels	
ESCA	cis	1	rs6740223	chr2:73653332	ALMS1P	chr2:73872046-73912692:+	0.42	4.3	2.98E-5	Metabolite levels	
ESCA	cis	1	rs6741892	chr2:38916970	GEMIN6	chr2:38978676-39009104:+	-0.43	-4.4	1.95E-5	5-HTT brain serotonin transporter levels	
ESCA	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.42	5.57	1.06E-7	Tuberculosis	
ESCA	cis	1	rs6756987	chr2:73687077	ALMS1P	chr2:73872046-73912692:+	0.42	4.34	2.55E-5	Metabolite levels	
ESCA	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.77	-6.26	3.36E-9	Triptolide cytotoxicity	
ESCA	cis	1	rs6763088	chr3:134254989	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs6763093	chr3:134254995	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.46	5.57	1.05E-7	Height	
ESCA	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.46	5.58	1.01E-7	Height	
ESCA	cis	1	rs6766897	chr3:134191303	ANAPC13	chr3:134196547-134204865:-	0.42	5.01	1.46E-6	Height	
ESCA	cis	1	rs6769885	chr3:134286913	ANAPC13	chr3:134196547-134204865:-	0.44	5.3	3.88E-7	Height	
ESCA	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.45	5.34	3.11E-7	Height	
ESCA	cis	1	rs6782563	chr3:134295959	ANAPC13	chr3:134196547-134204865:-	-0.44	-5.35	3.0E-7	Height	
ESCA	cis	1	rs6785027	chr3:134211649	ANAPC13	chr3:134196547-134204865:-	-0.48	-5.83	2.95E-8	Height	
ESCA	cis	1	rs6787371	chr3:134254991	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.46	5.38	2.66E-7	Height	
ESCA	cis	1	rs6793487	chr3:134299426	ANAPC13	chr3:134196547-134204865:-	-0.44	-5.35	3.0E-7	Height	
ESCA	cis	1	rs6800862	chr3:134228628	ANAPC13	chr3:134196547-134204865:-	0.46	5.6	9.31E-8	Height	
ESCA	cis	1	rs6801596	chr3:134252114	ANAPC13	chr3:134196547-134204865:-	0.44	5.3	3.83E-7	Height	
ESCA	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.46	5.54	1.24E-7	Height	
ESCA	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.46	5.6	9.31E-8	Height	
ESCA	cis	1	rs6806417	chr3:134211446	ANAPC13	chr3:134196547-134204865:-	-0.47	-5.75	4.34E-8	Height	
ESCA	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.6	-6.8	2.04E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs6827617	chr4:76916146	NAAA	chr4:76831809-76862166:-	-0.34	-4.28	3.17E-5	Longevity	
ESCA	cis	1	rs6862814	chr5:150245259	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.47	6.97	8.0E-11	Crohn's disease	
ESCA	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.71	6.93	1.01E-10	Type 2 diabetes	
ESCA	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.8	-11.06	1.86E-21	Response to antipsychotic treatment	
ESCA	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.31	-4.38	2.14E-5	Homocysteine levels	
ESCA	cis	1	rs6923124	chr6:49419864	MUT	chr6:49398994-49431031:-	0.47	5.1	9.62E-7	Folate pathway vitamin levels	
ESCA	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.8	11.02	2.41E-21	Response to antipsychotic treatment	
ESCA	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.59	-4.53	1.18E-5	Diabetic kidney disease	
ESCA	cis	1	rs6933094	chr6:150297603	ULBP2	chr6:150263136-150270366:+	0.53	4.56	1.03E-5	Radiation response	
ESCA	cis	1	rs6933377	chr6:86705255	SNHG5	chr6:86386726-86388451:-	0.45	5.52	1.38E-7	Response to antipsychotic treatment	
ESCA	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.63	-7.2	2.24E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.48	-7.24	1.86E-11	Crohn's disease	
ESCA	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.64	-7.52	3.79E-12	Response to antipsychotic treatment	
ESCA	cis	1	rs6945843	chr7:65734783	NCRNA00174	chr7:65841032-65865395:-	0.44	5.28	4.16E-7	Aortic root size	
ESCA	cis	1	rs6946143	chr7:65579722	NCRNA00174	chr7:65841032-65865395:-	-0.4	-4.71	5.42E-6	Aortic root size	
ESCA	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.48	-7.28	1.49E-11	Crohn's disease	
ESCA	cis	1	rs6952407	chr7:66045512	NCRNA00174	chr7:65841032-65865395:-	0.44	5.25	4.74E-7	Cotinine glucuronidation	
ESCA	cis	1	rs6956179	chr7:65806659	NCRNA00174	chr7:65841032-65865395:-	0.42	4.9	2.31E-6	Aortic root size	
ESCA	cis	1	rs6957199	chr7:65978519	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs6958271	chr7:65979331	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5.07	1.08E-6	Aortic root size	
ESCA	cis	1	rs6958277	chr7:65979349	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5.07	1.08E-6	Aortic root size	
ESCA	cis	1	rs6958484	chr7:65599446	NCRNA00174	chr7:65841032-65865395:-	0.43	5.27	4.41E-7	Aortic root size	
ESCA	cis	1	rs6958520	chr7:66151453	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.15	7.67E-7	Aortic root size	
ESCA	cis	1	rs6961155	chr7:65933295	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5	1.5E-6	Aortic root size	
ESCA	cis	1	rs6961717	chr7:65587537	NCRNA00174	chr7:65841032-65865395:-	0.43	5.27	4.41E-7	Aortic root size	
ESCA	cis	1	rs6961990	chr7:65888570	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs6963646	chr7:65685767	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	5.99E-7	Aortic root size	
ESCA	cis	1	rs6970030	chr7:65968679	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs6975195	chr7:66124774	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.15E-7	Aortic root size	
ESCA	cis	1	rs6979382	chr7:65886375	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	0.35	4.86	2.84E-6	Bone mineral density	
ESCA	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	0.35	4.86	2.76E-6	Bone mineral density	
ESCA	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.53	6.57	6.9E-10	Cognitive function	
ESCA	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.54	6.65	4.52E-10	Metabolite levels	
ESCA	cis	1	rs709595	chr7:65817333	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs709597	chr7:65825983	NCRNA00174	chr7:65841032-65865395:-	0.44	5.36	2.91E-7	Aortic root size	
ESCA	cis	1	rs7105282	chr11:47805614	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.21	7.31E-22	Subjective well-being	
ESCA	cis	1	rs7107356	chr11:47676170	C1QTNF4	chr11:47611216-47615961:-	0.42	5.96	1.54E-8	Neuroticism	
ESCA	cis	1	rs7111	chr15:90373873	AP3S2	chr15:90373832-90456222:-	-0.52	-5.4	2.42E-7	Type 2 diabetes	
ESCA	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.48	-5.23	5.28E-7	Forced vital capacity	
ESCA	cis	1	rs7120333	chr11:47817441	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.22	6.77E-22	Subjective well-being	
ESCA	cis	1	rs71327718	chr3:125592857	LOC100125556	chr3:125635444-125648865:+	0.59	5.35	2.99E-7	Metabolite levels (HVA/5-HIAA ratio)	
ESCA	cis	1	rs7134594	chr12:110000193	MMAB	chr12:109991523-110011358:-	-0.34	-4.82	3.37E-6	HDL cholesterol	
ESCA	cis	1	rs7144423	chr14:35572547	PPP2R3C	chr14:35554679-35591679:-	0.53	4.59	8.97E-6	Atopic dermatitis	
ESCA	cis	1	rs7153587	chr14:74509660	LIN52	chr14:74551656-74667117:+	0.31	4.33	2.59E-5	Common traits (Other)	
ESCA	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.34	-4.68	6.06E-6	Common traits (Other)	
ESCA	cis	1	rs7157940	chr14:94563193	IFI27L1	chr14:94547639-94569059:+	0.44	5.14	8.13E-7	Anthropometric traits	
ESCA	cis	1	rs7172118	chr15:78862453	CHRNA3	chr15:78885397-78913322:-	-0.45	-4.39	2.06E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.27	4.48	1.43E-5	Eye color traits	
ESCA	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.27	4.48	1.43E-5	Eye color traits	
ESCA	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.26	4.4	1.96E-5	Eye color traits	
ESCA	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.27	-4.48	1.43E-5	Eye color traits	
ESCA	cis	1	rs7256759	chr19:12065010	ZNF763	chr19:12035900-12091196:+	-0.63	-4.78	3.88E-6	Multiple sclerosis	
ESCA	cis	1	rs72644212	chr10:81782514	LOC219347	chr10:81805991-81838949:-	0.52	4.87	2.67E-6	Chronic obstructive pulmonary disease-related biomarkers	
ESCA	cis	1	rs72644213	chr10:81783660	LOC219347	chr10:81805991-81838949:-	0.51	4.81	3.47E-6	Chronic obstructive pulmonary disease-related biomarkers	
ESCA	cis	1	rs72768397	chr1:247219411	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.11E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.71	7.6	2.43E-12	Diastolic blood pressure	
ESCA	cis	1	rs73282255	chr5:150223647	LOC134466	chr5:150310000-150326146:-	0.51	4.73	4.83E-6	Crohn's disease	
ESCA	cis	1	rs73284126	chr5:150261307	LOC134466	chr5:150310000-150326146:-	0.57	5.67	6.45E-8	Crohn's disease	
ESCA	cis	1	rs73284141	chr5:150266086	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs73509026	chr19:12059467	ZNF763	chr19:12035900-12091196:+	-0.67	-5.02	1.34E-6	Multiple sclerosis	
ESCA	cis	1	rs73509052	chr19:12071802	ZNF763	chr19:12035900-12091196:+	-0.67	-5.02	1.34E-6	Multiple sclerosis	
ESCA	cis	1	rs73510924	chr19:12090150	ZNF763	chr19:12035900-12091196:+	-0.59	-4.56	1.01E-5	Multiple sclerosis	
ESCA	cis	1	rs73510930	chr19:12091762	ZNF763	chr19:12035900-12091196:+	-0.59	-4.42	1.85E-5	Multiple sclerosis	
ESCA	cis	1	rs7356093	chr3:134238753	ANAPC13	chr3:134196547-134204865:-	0.44	5.22	5.42E-7	Height	
ESCA	cis	1	rs7359981	chr19:12091659	ZNF763	chr19:12035900-12091196:+	-0.59	-4.42	1.85E-5	Multiple sclerosis	
ESCA	cis	1	rs736344	chr12:110001195	MMAB	chr12:109991523-110011358:-	-0.34	-4.82	3.37E-6	HDL cholesterol	
ESCA	cis	1	rs7371896	chr3:134249769	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs7374158	chr3:134270156	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs7374325	chr3:134275601	ANAPC13	chr3:134196547-134204865:-	0.44	5.22	5.42E-7	Height	
ESCA	cis	1	rs73943920	chr2:86186195	POLR1A	chr2:86253453-86333278:-	-0.45	-4.24	3.78E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
ESCA	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.26	4.3	3.02E-5	Eye color traits	
ESCA	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.67	-5.09	9.97E-7	Plasma clusterin levels	
ESCA	cis	1	rs7426847	chr3:134267519	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs7427492	chr3:134261654	ANAPC13	chr3:134196547-134204865:-	0.44	5.22	5.42E-7	Height	
ESCA	cis	1	rs7428326	chr3:134251184	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs7429866	chr3:134236306	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.07	1.09E-6	Height	
ESCA	cis	1	rs7432268	chr3:134242051	ANAPC13	chr3:134196547-134204865:-	0.44	5.22	5.42E-7	Height	
ESCA	cis	1	rs7433663	chr3:134235790	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs7433991	chr3:134312292	ANAPC13	chr3:134196547-134204865:-	0.44	5.33	3.36E-7	Height	
ESCA	cis	1	rs7436021	chr4:76905472	NAAA	chr4:76831809-76862166:-	-0.33	-4.24	3.78E-5	Longevity	
ESCA	cis	1	rs74372131	chr10:81787214	LOC219347	chr10:81805991-81838949:-	0.51	4.78	4.03E-6	Chronic obstructive pulmonary disease-related biomarkers	
ESCA	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.27	4.48	1.43E-5	Eye color traits	
ESCA	cis	1	rs75071288	chr5:150224379	LOC134466	chr5:150310000-150326146:-	0.54	5.12	8.81E-7	Crohn's disease	
ESCA	cis	1	rs7511962	chr1:247212122	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.1E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs7512150	chr1:247212326	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.1E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs7515491	chr1:46355079	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.37	2.27E-5	Body mass index	
ESCA	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.69	-5.04	1.24E-6	Plasma clusterin levels	
ESCA	cis	1	rs7519795	chr1:247212126	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.1E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs7522601	chr1:46419021	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.56	1.03E-5	Body mass index	
ESCA	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.63	8.24	5.85E-14	Homocysteine levels	
ESCA	cis	1	rs7524495	chr1:46266932	CCDC163P	chr1:45960581-45965646:-	-0.36	-4.34	2.55E-5	Body mass index	
ESCA	cis	1	rs7528684	chr1:157670816	FCRL3	chr1:157646278-157670775:-	0.27	4.58	9.33E-6	Type 1 diabetes autoantibodies	
ESCA	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.67	-4.97	1.71E-6	Plasma clusterin levels	
ESCA	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.77	-9.98	1.67E-18	Homocysteine levels	
ESCA	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.64	-8.37	2.77E-14	Homocysteine levels	
ESCA	cis	1	rs7539932	chr1:46292354	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.53	1.13E-5	Body mass index	
ESCA	cis	1	rs7540325	chr1:46338217	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.67	6.45E-6	Body mass index	
ESCA	cis	1	rs7546342	chr1:247213292	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.1E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs7549410	chr1:247214167	ZNF670	chr1:247200087-247242069:-	-0.42	-4.54	1.1E-5	Response to taxane treatment (docetaxel)	
ESCA	cis	1	rs7550746	chr1:46351719	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.5	1.29E-5	Body mass index	
ESCA	cis	1	rs7556436	chr1:46363880	CCDC163P	chr1:45960581-45965646:-	0.37	4.67	6.35E-6	Body mass index	
ESCA	cis	1	rs7556615	chr1:46461369	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.53	1.14E-5	Body mass index	
ESCA	cis	1	rs7562170	chr2:28943516	TRMT61B	chr2:29072690-29093175:-	0.34	4.29	3.13E-5	Body mass index	
ESCA	cis	1	rs7566279	chr2:281178	SH3YL1	chr2:218138-264810:-	-0.6	-7.84	6.19E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs75774363	chr5:150223722	LOC134466	chr5:150310000-150326146:-	0.5	4.6	8.44E-6	Crohn's disease	
ESCA	cis	1	rs75824542	chr14:74523047	LIN52	chr14:74551656-74667117:+	0.31	4.35	2.45E-5	Common traits (Other)	
ESCA	cis	1	rs7583255	chr2:73797996	ALMS1P	chr2:73872046-73912692:+	0.43	4.24	3.8E-5	Metabolite levels	
ESCA	cis	1	rs7584575	chr2:73666402	ALMS1P	chr2:73872046-73912692:+	0.42	4.3	2.98E-5	Metabolite levels	
ESCA	cis	1	rs7585004	chr2:73666645	ALMS1P	chr2:73872046-73912692:+	0.42	4.61	8.39E-6	Metabolite levels	
ESCA	cis	1	rs7586463	chr2:73798476	ALMS1P	chr2:73872046-73912692:+	0.43	4.24	3.8E-5	Metabolite levels	
ESCA	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.7	-5.09	1.02E-6	Plasma clusterin levels	
ESCA	cis	1	rs75913297	chr10:81789845	LOC219347	chr10:81805991-81838949:-	0.51	4.79	3.82E-6	Chronic obstructive pulmonary disease-related biomarkers	
ESCA	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.97	-10.19	4.34E-19	Triptolide cytotoxicity	
ESCA	cis	1	rs7595075	chr2:264019	SH3YL1	chr2:218138-264810:-	-0.6	-8.05	1.78E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs7598396	chr2:73652628	ALMS1P	chr2:73872046-73912692:+	0.42	4.29	3.11E-5	Metabolite levels	
ESCA	cis	1	rs7598876	chr2:28974466	TRMT61B	chr2:29072690-29093175:-	-0.35	-4.36	2.35E-5	Body mass index	
ESCA	cis	1	rs7605824	chr2:280819	SH3YL1	chr2:218138-264810:-	0.61	8.31	4.09E-14	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs7609851	chr3:156638503	LEKR1	chr3:156544076-156763918:+	-0.47	-4.29	3.08E-5	Bone mineral density	
ESCA	cis	1	rs7611611	chr3:134307877	ANAPC13	chr3:134196547-134204865:-	0.44	5.33	3.36E-7	Height	
ESCA	cis	1	rs7611828	chr3:134250325	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.57	-5.65	7.31E-8	Blood pressure (smoking interaction)	
ESCA	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.57	5.48	1.67E-7	Blood pressure (smoking interaction)	
ESCA	cis	1	rs7619451	chr3:134233238	ANAPC13	chr3:134196547-134204865:-	0.38	4.43	1.71E-5	Height	
ESCA	cis	1	rs763014	chr16:675680	WFIKKN1	chr16:679239-684116:+	0.37	4.35	2.41E-5	Height	
ESCA	cis	1	rs7630874	chr3:134293291	ANAPC13	chr3:134196547-134204865:-	-0.43	-5.03	1.33E-6	Height	
ESCA	cis	1	rs7637227	chr3:134244155	ANAPC13	chr3:134196547-134204865:-	0.44	5.26	4.65E-7	Height	
ESCA	cis	1	rs7639514	chr3:156576067	LEKR1	chr3:156544076-156763918:+	-0.46	-4.53	1.16E-5	Bone mineral density	
ESCA	cis	1	rs76433514	chr5:150306532	LOC134466	chr5:150310000-150326146:-	0.49	4.4	1.94E-5	Crohn's disease	
ESCA	cis	1	rs7645295	chr3:134307734	ANAPC13	chr3:134196547-134204865:-	0.44	5.23	5.29E-7	Height	
ESCA	cis	1	rs7648990	chr3:134244390	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.61	-4.7	5.57E-6	Tumor biomarkers	
ESCA	cis	1	rs76542740	chr15:43891512	CATSPER2	chr15:43922774-43959900:-	-0.69	-7.14	3.09E-11	Tumor biomarkers	
ESCA	cis	1	rs76548544	chr5:150223515	LOC134466	chr5:150310000-150326146:-	0.51	4.73	4.83E-6	Crohn's disease	
ESCA	cis	1	rs7655841	chr4:129890790	C4orf33	chr4:130014829-130033842:+	0.48	6.76	2.42E-10	Chronic obstructive pulmonary disease (moderate to severe)	
ESCA	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	0.94	18.1	1.86E-40	Birdshot chorioretinopathy	
ESCA	cis	1	rs7705542	chr5:150228318	LOC134466	chr5:150310000-150326146:-	0.54	5.08	1.05E-6	Crohn's disease	
ESCA	cis	1	rs7709388	chr5:150246539	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs7709464	chr5:150269441	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs7709650	chr5:150246685	LOC134466	chr5:150310000-150326146:-	0.53	5.25	4.8E-7	Crohn's disease	
ESCA	cis	1	rs7714415	chr5:150270292	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs7714584	chr5:150270420	LOC134466	chr5:150310000-150326146:-	0.57	5.59	9.72E-8	Crohn's disease	
ESCA	cis	1	rs7715981	chr5:150258107	LOC134466	chr5:150310000-150326146:-	0.57	5.65	7.09E-8	Crohn's disease	
ESCA	cis	1	rs7716903	chr5:150258574	LOC134466	chr5:150310000-150326146:-	0.55	5.46	1.81E-7	Crohn's disease	
ESCA	cis	1	rs7724036	chr5:150284808	LOC134466	chr5:150310000-150326146:-	-0.5	-5.02	1.34E-6	Crohn's disease	
ESCA	cis	1	rs7724558	chr5:150328866	LOC134466	chr5:150310000-150326146:-	0.64	5.3	3.84E-7	Crohn's disease	
ESCA	cis	1	rs7732643	chr5:150261436	LOC134466	chr5:150310000-150326146:-	0.57	5.67	6.45E-8	Crohn's disease	
ESCA	cis	1	rs7732945	chr5:150261601	LOC134466	chr5:150310000-150326146:-	0.57	5.67	6.45E-8	Crohn's disease	
ESCA	cis	1	rs7734778	chr5:150256556	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs7734928	chr5:150256613	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs7736554	chr5:150258308	LOC134466	chr5:150310000-150326146:-	0.55	5.46	1.81E-7	Crohn's disease	
ESCA	cis	1	rs7736873	chr5:150258482	LOC134466	chr5:150310000-150326146:-	0.55	5.46	1.81E-7	Crohn's disease	
ESCA	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.8	-11.06	1.86E-21	Response to antipsychotic treatment	
ESCA	cis	1	rs7750918	chr6:49430082	MUT	chr6:49398994-49431031:-	0.45	4.83	3.12E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.61	-6.99	7.02E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.33	-4.63	7.69E-6	Homocysteine levels	
ESCA	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.66	-7.84	6.19E-13	Response to antipsychotic treatment	
ESCA	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.79	-10.76	1.22E-20	Response to antipsychotic treatment	
ESCA	cis	1	rs7769491	chr6:138263885	TNFAIP3	chr6:138188581-138204445:+	-0.44	-4.29	3.07E-5	Cardiac Troponin-T levels	
ESCA	cis	1	rs77698001	chr5:150250367	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.61	-6.99	7.02E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs7781698	chr7:65896312	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.05	1.2E-6	Aortic root size	
ESCA	cis	1	rs7782320	chr7:66177098	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.18	6.56E-7	Aortic root size	
ESCA	cis	1	rs7783613	chr7:65805261	NCRNA00174	chr7:65841032-65865395:-	0.43	5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs7783924	chr7:66209057	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5.13	8.41E-7	Aortic root size	
ESCA	cis	1	rs7785213	chr7:66138978	NCRNA00174	chr7:65841032-65865395:-	0.43	5.18	6.63E-7	Aortic root size	
ESCA	cis	1	rs778685	chr7:65836176	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs778694	chr7:65871558	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs778696	chr7:65870813	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs778699	chr7:65868290	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs778706	chr7:65860424	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs778710	chr7:65854834	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs778722	chr7:65844828	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs778726	chr7:65828731	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.4	5.33	3.28E-7	Tuberculosis	
ESCA	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.42	5.68	6.31E-8	Tuberculosis	
ESCA	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.4	5.28	4.09E-7	Tuberculosis	
ESCA	cis	1	rs7788576	chr7:66148302	NCRNA00174	chr7:65841032-65865395:-	0.43	5.15	7.67E-7	Aortic root size	
ESCA	cis	1	rs7789184	chr7:66210195	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5.13	8.41E-7	Aortic root size	
ESCA	cis	1	rs7789554	chr7:65946038	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5	1.5E-6	Aortic root size	
ESCA	cis	1	rs7789768	chr7:65938980	NCRNA00174	chr7:65841032-65865395:-	-0.42	-5	1.5E-6	Aortic root size	
ESCA	cis	1	rs7792762	chr7:66004138	NCRNA00174	chr7:65841032-65865395:-	-0.41	-4.8	3.56E-6	Aortic root size	
ESCA	cis	1	rs7801282	chr7:65613687	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.04E-7	Aortic root size	
ESCA	cis	1	rs785464	chr1:46523089	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs785471	chr1:46518677	CCDC163P	chr1:45960581-45965646:-	-0.38	-4.81	3.5E-6	Body mass index	
ESCA	cis	1	rs785479	chr1:46492144	CCDC163P	chr1:45960581-45965646:-	-0.39	-4.81	3.4E-6	Body mass index	
ESCA	cis	1	rs785481	chr1:46554518	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs785485	chr1:46574424	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs785488	chr1:46576095	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs785489	chr1:46576390	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs785491	chr1:46583418	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs785492	chr1:46583607	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs785494	chr1:46586626	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs785495	chr1:46587887	CCDC163P	chr1:45960581-45965646:-	-0.39	-4.94	2.0E-6	Body mass index	
ESCA	cis	1	rs785503	chr1:46595868	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs785520	chr1:46568836	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.81	11.22	6.77E-22	Response to antipsychotic treatment	
ESCA	cis	1	rs79199019	chr14:35581125	PPP2R3C	chr14:35554679-35591679:-	0.53	4.59	8.97E-6	Atopic dermatitis	
ESCA	cis	1	rs7922685	chr10:28489647	MKX	chr10:27961804-28034778:-	-0.37	-4.27	3.31E-5	Bone mineral density;Bone mineral density (paediatric, skull)	
ESCA	cis	1	rs7927771	chr11:47781306	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.18	8.91E-22	Subjective well-being	
ESCA	cis	1	rs79436302	chr14:35578797	PPP2R3C	chr14:35554679-35591679:-	0.53	4.59	8.97E-6	Atopic dermatitis	
ESCA	cis	1	rs7947730	chr11:47786184	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.18	8.91E-22	Subjective well-being	
ESCA	cis	1	rs7953014	chr12:109998097	MMAB	chr12:109991523-110011358:-	-0.33	-4.61	8.36E-6	HDL cholesterol	
ESCA	cis	1	rs7954144	chr12:110015893	MMAB	chr12:109991523-110011358:-	-0.34	-4.87	2.73E-6	HDL cholesterol	
ESCA	cis	1	rs7964021	chr12:109997645	MMAB	chr12:109991523-110011358:-	-0.33	-4.61	8.36E-6	HDL cholesterol	
ESCA	cis	1	rs79716074	chr2:277003	SH3YL1	chr2:218138-264810:-	-0.6	-8.05	1.78E-13	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs8003506	chr14:75586288	EIF2B2	chr14:75469612-75476292:+	-0.37	-4.45	1.64E-5	Height	
ESCA	cis	1	rs80075680	chr5:150223737	LOC134466	chr5:150310000-150326146:-	0.5	4.6	8.44E-6	Crohn's disease	
ESCA	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.52	-7.37	8.88E-12	IgG glycosylation	
ESCA	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.54	-5.87	2.5E-8	Type 2 diabetes	
ESCA	cis	1	rs8031948	chr15:78816057	CHRNA3	chr15:78885397-78913322:-	-0.5	-4.72	5.04E-6	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs8031948	chr15:78816057	CHRNA5	chr15:78857906-78886458:+	-0.45	-4.59	9.12E-6	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs8034191	chr15:78806023	CHRNA3	chr15:78885397-78913322:-	-0.44	-4.26	3.46E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs8034191	chr15:78806023	CHRNA5	chr15:78857906-78886458:+	-0.41	-4.3	2.91E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs807670	chr22:19154608	SLC25A1	chr22:19163095-19166301:-	-0.39	-4.27	3.37E-5	Metabolite levels	
ESCA	cis	1	rs809775	chr1:46538040	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs811880	chr7:65818646	NCRNA00174	chr7:65841032-65865395:-	-0.43	-5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs8138799	chr22:24556902	SUSD2	chr22:24577444-24585074:+	0.93	5.67	6.42E-8	Amyotrophic lateral sclerosis	
ESCA	cis	1	rs8141797	chr22:24582041	SUSD2	chr22:24577444-24585074:+	-0.88	-5.39	2.51E-7	Amyotrophic lateral sclerosis	
ESCA	cis	1	rs8192482	chr15:78886198	CHRNA3	chr15:78885397-78913322:-	-0.49	-4.74	4.82E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs8192482	chr15:78886198	CHRNA5	chr15:78857906-78886458:+	-0.45	-4.6	8.5E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	0.71	6.65	4.38E-10	Type 2 diabetes	
ESCA	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.73	7.28	1.43E-11	Type 2 diabetes	
ESCA	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.73	7.2	2.28E-11	Type 2 diabetes	
ESCA	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	0.73	7.37	8.93E-12	Type 2 diabetes	
ESCA	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	0.73	7.37	8.93E-12	Type 2 diabetes	
ESCA	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	0.73	7.37	8.93E-12	Type 2 diabetes	
ESCA	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.71	6.7	3.48E-10	Type 2 diabetes	
ESCA	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	0.72	6.75	2.69E-10	Type 2 diabetes	
ESCA	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	0.71	6.65	4.38E-10	Type 2 diabetes	
ESCA	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.76	-7.2	2.23E-11	Type 2 diabetes	
ESCA	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.73	-7.87	5.29E-13	Type 2 diabetes	
ESCA	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	0.71	6.65	4.38E-10	Type 2 diabetes	
ESCA	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.8	8.48	1.43E-14	Type 2 diabetes	
ESCA	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	0.71	6.65	4.38E-10	Type 2 diabetes	
ESCA	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.51	6.09	8.36E-9	Kawasaki disease	
ESCA	cis	1	rs875971	chr7:65617595	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	6.1E-7	Aortic root size	
ESCA	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.52	-6.77	2.31E-10	Cognitive function	
ESCA	cis	1	rs877710	chr12:109993976	MMAB	chr12:109991523-110011358:-	-0.33	-4.53	1.16E-5	HDL cholesterol	
ESCA	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.61	-8.22	6.62E-14	Homocysteine levels	
ESCA	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.65	-7.6	2.37E-12	Response to antipsychotic treatment	
ESCA	cis	1	rs888192	chr12:109995097	MMAB	chr12:109991523-110011358:-	0.32	4.48	1.41E-5	HDL cholesterol	
ESCA	cis	1	rs9213	chr2:218386	SH3YL1	chr2:218138-264810:-	-0.59	-7.52	3.82E-12	Spherical equivalent (joint main effects and education interaction)	
ESCA	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.71	7.1	3.85E-11	Type 2 diabetes	
ESCA	cis	1	rs9289275	chr3:125648659	LOC100125556	chr3:125635444-125648865:+	0.57	5.52	1.35E-7	Blood pressure (smoking interaction)	
ESCA	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.52	6.19	4.8E-9	Height	
ESCA	cis	1	rs9289475	chr3:134236459	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs9289476	chr3:134237103	ANAPC13	chr3:134196547-134204865:-	0.44	5.3	3.83E-7	Height	
ESCA	cis	1	rs9289478	chr3:134268619	ANAPC13	chr3:134196547-134204865:-	0.44	5.3	3.83E-7	Height	
ESCA	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.85	11.18	8.84E-22	Plasma homocysteine levels (post-methionine load test)	
ESCA	cis	1	rs9296616	chr6:49414235	MUT	chr6:49398994-49431031:-	0.44	4.79	3.75E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs9296617	chr6:49428360	MUT	chr6:49398994-49431031:-	0.46	4.93	2.1E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs9307050	chr4:76905649	NAAA	chr4:76831809-76862166:-	-0.33	-4.24	3.78E-5	Longevity	
ESCA	cis	1	rs931058	chr5:150333698	LOC134466	chr5:150310000-150326146:-	0.64	4.94	1.98E-6	Crohn's disease	
ESCA	cis	1	rs931794	chr15:78826180	CHRNA5	chr15:78857906-78886458:+	0.4	5	1.48E-6	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs9324660	chr5:150257054	LOC134466	chr5:150310000-150326146:-	0.56	5.53	1.3E-7	Crohn's disease	
ESCA	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.47	5.54	1.23E-7	Height	
ESCA	cis	1	rs937495	chr7:65779798	NCRNA00174	chr7:65841032-65865395:-	0.43	5.16	7.16E-7	Aortic root size	
ESCA	cis	1	rs9394931	chr6:42873245	PEX6	chr6:42931613-42946981:-	-0.47	-5.68	6.34E-8	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
ESCA	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.31	-4.38	2.14E-5	Homocysteine levels	
ESCA	cis	1	rs941653	chr14:35592538	PPP2R3C	chr14:35554679-35591679:-	0.51	4.25	3.69E-5	Atopic dermatitis	
ESCA	cis	1	rs9429183	chr1:46524582	CCDC163P	chr1:45960581-45965646:-	-0.37	-4.74	4.75E-6	Body mass index	
ESCA	cis	1	rs945635	chr1:157670290	FCRL3	chr1:157646278-157670775:-	0.29	4.97	1.69E-6	Type 1 diabetes autoantibodies	
ESCA	cis	1	rs9463473	chr6:49380121	MUT	chr6:49398994-49431031:-	0.49	5.19	6.25E-7	Folate pathway vitamin levels	
ESCA	cis	1	rs9463474	chr6:49380199	MUT	chr6:49398994-49431031:-	0.49	5.19	6.25E-7	Folate pathway vitamin levels	
ESCA	cis	1	rs9463475	chr6:49380899	MUT	chr6:49398994-49431031:-	-0.48	-5.14	7.79E-7	Folate pathway vitamin levels	
ESCA	cis	1	rs9463477	chr6:49386446	MUT	chr6:49398994-49431031:-	0.48	5.11	9.08E-7	Folate pathway vitamin levels	
ESCA	cis	1	rs9463479	chr6:49393275	MUT	chr6:49398994-49431031:-	0.49	5.23	5.16E-7	Folate pathway vitamin levels	
ESCA	cis	1	rs9463480	chr6:49400795	MUT	chr6:49398994-49431031:-	0.46	5	1.47E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs946529	chr1:46485548	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.01	1.43E-6	Body mass index	
ESCA	cis	1	rs9473549	chr6:49380020	MUT	chr6:49398994-49431031:-	0.47	5.02	1.35E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs9473552	chr6:49387154	MUT	chr6:49398994-49431031:-	0.48	5.11	9.08E-7	Folate pathway vitamin levels	
ESCA	cis	1	rs9473553	chr6:49395977	MUT	chr6:49398994-49431031:-	0.49	5.23	5.16E-7	Folate pathway vitamin levels	
ESCA	cis	1	rs9473555	chr6:49409487	MUT	chr6:49398994-49431031:-	0.46	5.04	1.25E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs9473560	chr6:49427918	MUT	chr6:49398994-49431031:-	0.46	4.93	2.1E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs9473561	chr6:49428755	MUT	chr6:49398994-49431031:-	0.46	4.93	2.1E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs9473563	chr6:49453651	MUT	chr6:49398994-49431031:-	0.44	4.65	6.85E-6	Folate pathway vitamin levels	
ESCA	cis	1	rs9491140	chr6:124691237	NKAIN2	chr6:124125069-125146784:+	0.42	5.16	7.42E-7	Neuroticism	
ESCA	cis	1	rs9491142	chr6:124693017	NKAIN2	chr6:124125069-125146784:+	0.4	4.78	3.99E-6	Neuroticism	
ESCA	cis	1	rs9527	chr10:104623578	C10orf32	chr10:104613967-104624718:+	-0.59	-6.48	1.08E-9	Arsenic metabolism	
ESCA	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.62	7.29	1.41E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.62	-7.1	3.95E-11	Response to antipsychotic treatment	
ESCA	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.59	-6.66	4.34E-10	Response to antipsychotic treatment	
ESCA	cis	1	rs9593	chr12:109994870	MMAB	chr12:109991523-110011358:-	-0.32	-4.36	2.37E-5	HDL cholesterol	
ESCA	cis	1	rs9624447	chr22:24681555	POM121L9P	chr22:24647589-24661490:+	-0.45	-6	1.3E-8	Gut microbiome composition (summer)	
ESCA	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.8	-11.02	2.4E-21	Response to antipsychotic treatment	
ESCA	cis	1	rs9653557	chr2:73795962	ALMS1P	chr2:73872046-73912692:+	0.43	4.24	3.8E-5	Metabolite levels	
ESCA	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.27	4.48	1.43E-5	Eye color traits	
ESCA	cis	1	rs968567	chr11:61595564	FADS2	chr11:61583728-61634825:+	0.48	4.44	1.71E-5	Blood metabolite levels;Rheumatoid arthritis;Glycerophospholipid levels	
ESCA	cis	1	rs9689	chr1:25688276	RHD	chr1:25598981-25656935:+	-0.45	-5.32	3.51E-7	Erythrocyte sedimentation rate	
ESCA	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.27	4.48	1.43E-5	Eye color traits	
ESCA	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.27	4.42	1.8E-5	Eye color traits	
ESCA	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.46	5.04	1.27E-6	Forced vital capacity	
ESCA	cis	1	rs9788721	chr15:78802869	CHRNA5	chr15:78857906-78886458:+	0.46	5.58	1.02E-7	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
ESCA	cis	1	rs9809619	chr3:134280948	ANAPC13	chr3:134196547-134204865:-	0.43	5.18	6.69E-7	Height	
ESCA	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.46	5.6	9.31E-8	Height	
ESCA	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.47	-5.62	8.22E-8	Height	
ESCA	cis	1	rs9819532	chr3:134288644	ANAPC13	chr3:134196547-134204865:-	0.44	5.3	3.88E-7	Height	
ESCA	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.71	7.64	1.95E-12	Diastolic blood pressure	
ESCA	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.71	7.64	1.95E-12	Diastolic blood pressure	
ESCA	cis	1	rs9826496	chr3:134224437	ANAPC13	chr3:134196547-134204865:-	0.46	5.6	9.31E-8	Height	
ESCA	cis	1	rs9827987	chr3:134272621	ANAPC13	chr3:134196547-134204865:-	0.44	5.22	5.42E-7	Height	
ESCA	cis	1	rs9828815	chr3:134265749	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.45	5.42	2.17E-7	Height	
ESCA	cis	1	rs9832785	chr3:134213070	ANAPC13	chr3:134196547-134204865:-	0.46	5.52	1.35E-7	Height	
ESCA	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.45	5.36	2.89E-7	Height	
ESCA	cis	1	rs9834970	chr3:36856030	DCLK3	chr3:36753913-36781352:-	0.34	4.44	1.68E-5	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);Bipolar disorder with mood-incongruent psychosis;Subjective response to lithium treatment;Bipolar disorder;Schizophrenia or bipolar disorder	
ESCA	cis	1	rs9835204	chr3:134261342	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.51	6.39	1.79E-9	Height	
ESCA	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-0.73	-7.95	3.23E-13	Diastolic blood pressure	
ESCA	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.71	7.64	1.95E-12	Diastolic blood pressure	
ESCA	cis	1	rs9850015	chr3:134269541	ANAPC13	chr3:134196547-134204865:-	0.44	5.22	5.42E-7	Height	
ESCA	cis	1	rs9851441	chr3:134315091	ANAPC13	chr3:134196547-134204865:-	0.44	5.24	5.08E-7	Height	
ESCA	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.46	5.57	1.05E-7	Height	
ESCA	cis	1	rs9856693	chr3:134306913	ANAPC13	chr3:134196547-134204865:-	0.44	5.33	3.36E-7	Height	
ESCA	cis	1	rs9863786	chr3:134247203	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs9864346	chr3:134312352	ANAPC13	chr3:134196547-134204865:-	0.44	5.33	3.36E-7	Height	
ESCA	cis	1	rs9864439	chr3:134298671	ANAPC13	chr3:134196547-134204865:-	0.44	5.35	3.0E-7	Height	
ESCA	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.74	-8.61	6.7E-15	Diastolic blood pressure	
ESCA	cis	1	rs9869981	chr3:134248801	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs9871305	chr3:134213538	ANAPC13	chr3:134196547-134204865:-	0.45	5.36	2.9E-7	Height	
ESCA	cis	1	rs9872999	chr3:133457514	TF	chr3:133419211-133497635:+	-0.58	-7.36	9.41E-12	Iron status biomarkers	
ESCA	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.71	7.64	1.95E-12	Diastolic blood pressure	
ESCA	cis	1	rs9876658	chr3:134179453	ANAPC13	chr3:134196547-134204865:-	-0.38	-4.86	2.84E-6	Height	
ESCA	cis	1	rs9883753	chr3:134247231	ANAPC13	chr3:134196547-134204865:-	0.44	5.3	3.83E-7	Height	
ESCA	cis	1	rs9884031	chr3:134256500	ANAPC13	chr3:134196547-134204865:-	0.44	5.25	4.9E-7	Height	
ESCA	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.26	4.3	3.02E-5	Eye color traits	
ESCA	cis	1	rs9909	chr11:47799775	C1QTNF4	chr11:47611216-47615961:-	-0.67	-11.18	8.91E-22	Subjective well-being	
ESCA	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.45	-5.36	2.89E-7	Height	
ESCA	cis	1	rs9985356	chr3:134232920	ANAPC13	chr3:134196547-134204865:-	-0.45	-5.45	1.86E-7	Height	
ESCA	cis	1	rs9986696	chr7:65704576	NCRNA00174	chr7:65841032-65865395:-	0.43	5.2	5.99E-7	Aortic root size	
ESCA	cis	1	rs9989967	chr3:134238964	ANAPC13	chr3:134196547-134204865:-	0.44	5.3	3.83E-7	Height	
ESCA	cis	1	rs9990351	chr3:134239191	ANAPC13	chr3:134196547-134204865:-	-0.45	-5.46	1.79E-7	Height	
ESCA	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.66	8.37	2.79E-14	Educational attainment	
ESCA	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.67	8.63	5.92E-15	Educational attainment	
ESCA	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.71	9.42	5.15E-17	Educational attainment	
ESCA	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.68	8.57	8.45E-15	Educational attainment	
ESCA	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.68	8.57	8.45E-15	Educational attainment	
ESCA	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.68	8.57	8.45E-15	Educational attainment	
ESCA	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.65	8.35	3.2E-14	Educational attainment	
ESCA	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.67	-8.72	3.5E-15	Educational attainment	
ESCA	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.69	8.6	7.3E-15	Educational attainment	
ESCA	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.69	8.59	7.61E-15	Educational attainment	
ESCA	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.69	8.79	2.28E-15	Educational attainment	
ESCA	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.71	9.42	5.15E-17	Educational attainment	
ESCA	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.67	8.63	5.92E-15	Educational attainment	
ESCA	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.72	9.37	6.72E-17	Educational attainment	
ESCA	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.68	8.57	8.45E-15	Educational attainment	
ESCA	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.68	8.57	8.45E-15	Educational attainment	
ESCA	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.71	9.42	5.15E-17	Educational attainment	
ESCA	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.71	9.42	5.15E-17	Educational attainment	
ESCA	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.69	8.91	1.13E-15	Educational attainment	
ESCA	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.69	8.59	7.61E-15	Educational attainment	
ESCA	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.69	8.79	2.33E-15	Educational attainment	
ESCA	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.72	9.37	6.72E-17	Educational attainment	
ESCA	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.69	8.92	1.05E-15	Educational attainment	
ESCA	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.67	-8.76	2.75E-15	Educational attainment	
ESCA	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.69	8.91	1.13E-15	Educational attainment	
ESCA	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.72	9.37	6.72E-17	Educational attainment	
ESCA	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.67	8.63	5.92E-15	Educational attainment	
ESCA	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.69	8.59	7.61E-15	Educational attainment	
ESCA	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.65	8.2	7.77E-14	Educational attainment	
ESCA	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.65	8.14	1.08E-13	Educational attainment	
ESCA	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.66	8.37	2.86E-14	Educational attainment	
ESCA	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.68	-8.26	5.28E-14	Educational attainment	
ESCA	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.65	8.18	8.5E-14	Educational attainment	
ESCA	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.71	9.42	5.15E-17	Educational attainment	
ESCA	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.69	8.91	1.13E-15	Educational attainment	
ESCA	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.68	8.57	8.45E-15	Educational attainment	
ESCA	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.68	8.57	8.45E-15	Educational attainment	
ESCA	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.71	9.42	5.15E-17	Educational attainment	
ESCA	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.67	8.63	5.92E-15	Educational attainment	
ESCA	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.72	9.37	6.72E-17	Educational attainment	
ESCA	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.71	9.42	5.15E-17	Educational attainment	
ESCA	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.68	8.57	8.45E-15	Educational attainment	
ESCA	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.7	-8.89	1.28E-15	Educational attainment	
ESCA	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.69	8.79	2.34E-15	Educational attainment	
ESCA	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.68	8.99	6.81E-16	Educational attainment	
ESCA	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.66	8.36	2.93E-14	Educational attainment	
ESCA	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.68	-8.5	1.29E-14	Educational attainment	
ESCA	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.67	8.63	6.1E-15	Educational attainment	
